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ABSTRACT
The epidemicity of metabolic diseases such as obesity and diabetes
globally has become a public health concern. Therefore, understanding
interactions of macronutrients such as glucose and micronutrients such as
vitamin A (VA) has become urgent. Both skeletal muscle and adipose tissues are
critical for the regulation of glucose homeostasis. Retinoid acid (RA) is an active
metabolite of retinol which mediates the major functions of VA. RA and insulin
signals have been shown to regulate glucose metabolism. However, their roles in
glucose metabolism in skeletal muscle and adipocytes remain to be revealed.
We postulate that insulin and RA signals may work together to regulate glucose
metabolism in skeletal muscle cells and adipocytes. In the first study, the glucose
transporter 4 (GLUT4) expression were measured in L6 myocyes treated with
increasing doses of RA in the absence or presence of insulin for 6 days. RA and
insulin were found to inhibit the expression levels of GLUT4 in L6 cells after 4
and 6 days of treatment. The synergy inhibition effects of RA and insulin on
GLUT4 can be observed at Day 4 with RA at 1 μM RA. To study the RA effects
on adipocytes, recombinant adenoviruses were used to overexpress retinoid X
receptor α (RXRα) and chicken ovalbumin upstream transcription factor II
(COUP-TFII), two transcription factors with the potential to mediate RA signaling.
3T3-L1 CARΔ1 cells were transfected with ad-β-gal, ad-RXRα or ad-COUPTFII
and treated with increasing RA doses during differentiation. Lipid accumulation
and GLUT4 protein level were examined. Interestingly, overexpression of RXRα
enhanced the inhibitory effects of RA on lipid accumulation. Moreover, the
inhibitory effect of RA on GLUT4 expression can be attenuated in the presence
of RXRα overexpression. The overexpression of COUPTFII may enhance the
inhibitory effects of RA on the expression of GLUT4. The fact that RA and insulin
synergized to inhibit the GLUT4 expression in L6 cells seems to indicate that
cautions should be taken when VA supplement is recommended for patients with
diabetes or obesity.
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CHAPTER ONE
INTRODUCTION
Glucose metabolism is of great importance to be completely understood.
Glucose is a common fuel for a variety of cells. For example, red blood cells in
the circulation are responsible for oxygen transport in the body. They can only
use glucose as an energy source.1 Neurons also prefer glucose as an energy
source, while other types of cells may obtain energy through protein and fat
metabolism.2 In addition, the abnormal glucose metabolism in the brain may lead
to the development of brain diseases like Alzheimer's disease.3
Another important function of cellular glucose metabolism is to regulate
the immune function of lymphocytes.4 The inefficient uptake of glucose in
lymphocytes can result in cell death, while excessive uptake of glucose will lead
to over activation of immune responses which may cause the development of
immune pathology.4 If we can understand the regulation of glucose metabolism,
it may be helpful for us to develop intervention methods for the prevention and
treatment of diseases related to immunology such as cancer5 or autoimmunity.6
What’s more, glucose metabolism is an essential part of the whole-body
glucose homeostasis. The pancreatic hormones, insulin, glucagon, and
somatostatin work together to regulate glucose homeostasis.7 Alterations of
glucose metabolism are associate with endocrine or nutritional chronic diseases
such as diabetes8 and obesity9. Changes in glucose metabolism such as
hyperglycemia in fasting and postprandial states are important biomarkers for the
early detection of myocardial infarction.10 In summary, the regulation of glucose
metabolism has constantly been studied to help us understand how to prevent
and treat chronic or acute diseases such as myocardial infarction, diabetes, and
obesity.
Muscle cells are critical players in the whole-body glucose metabolism.
This is because muscle makes up to one third of human body mass.11 Skeletal
1

muscle is one important type of muscle, which contributes significantly to glucose
homeostasis. Skeletal muscle can either store glucose or use it directly to
generate energy under different metabolic conditions after the uptake of
glucose.12Skeletal muscle is the major place for glucose utilization.12 It uses a
significant amount of glucose for energy production in physical activities. In
addition, it also converts excessive glucose into glycogen for the use as a quick
source of energy intracellularly.12 Therefore, understanding the muscle glucose
metabolism is relevant to the intervention of the development of metabolic
diseases.
In healthy subjects, the blood glucose level is controlled in a narrow range
from 4.0 to 5.9 mmol/L.13 This is achieved through the balance of glucose uptake
and usage. As an aldose, glucose could not enter cells freely without the help of
carrier proteins. One type of these proteins is known as glucose transporters
(GLUTs).14 Glucose uptake is mediated by GLUTs in cells including skeletal
muscle cells. GLUT1, GLUT4, and GLUT5 are 3 isoforms of GLUTs that mediate
the uptake of glucose in skeletal muscle.14 Insulin can stimulate the uptake of
glucose in skeletal muscle in the postprandial state.12
Insulin is important for the transport and disposal of glucose especially in
peripheral tissue such as muscle and adipose tissues.15 The sensitivity of muscle
in response to insulin is important in maintaining normal glucose level. Insulin
was first found to be able to stimulate the movement of a GLUT from intracellular
poor to the plasma membrane in 1980.16 It has been thought that the main GLUT
mediating insulin-stimulated glucose uptake is GLUT4.17 GLUT4 locates
specifically in cells of the striated muscle and adipose tissues.15 GLUT4 moves
rapidly from the intracellular storage locations to the plasma membrane when
cells are stimulated by insulin.17 Once present on the cell membrane, GLUT4
begins to mediate the uptake of glucose into the skeletal muscle cells. Insulinmediated translocation of GLUT4 has been considered as a critical step for the
glucose uptake in skeletal muscle.17
2

The insulin-induced GLUT4 translocation also exists in adipocytes.18
Adipose tissues are not only a storage place for fat but also an endocrine organ
for the regulation of lipid and glucose homeostasis.18 They play critical roles in
the maintenance of body health. The major storage form of fat in adipocytes is
triglyceride, which is a glycerol backbone esterified to three fatty acids (FAs).18
FAs can be derived from dietary fat or synthesized de novo from proteins or
carbohydrates in the body.18 Adipocytes include white adipocytes19 and brown
adipocytes.20 White adipocytes are responsible for the storage of fat19, whereas
brown adipocytes are responsible for the generation of heat to maintain the body
temperature.20 Enzymes in adipocytes catalyze the hydrolysis of triglycerides for
the generation of free FA and glycerol in the body. Adipocytes are not a simple
site for fat storage; they secrete important endocrine hormones such as leptin
and adiponectin to regulate metabolism in the whole body.19 Both leptin and
adiponectin regulate metabolism to control the body mass in healthy subjects.19
However, the regulatory functions of leptin and adiponectin towards body mass
begin to have problems when the body mass of human subjects increases.20
Due to the economic development and improvement of education, people
begin to pay more attention to the prevalence of overweight or obesity in America
and other parts of the world.21 Increased food consumption and decreased
exercise are the common causes of overweight or obesity. 21 Individuals in a
population categorized as underweight, normal weight, overweight or obese
group based on body mass index (BMI).22BMI is determined as the body mass
(kg) divided by the square of the body height (meters). kg/m2 is the generally unit
of BMI. BMI categories22 are (1) underweight: <18.5, (2) normal weight: 18.5-25,
(3) overweight: 25-30, (4) obese: >30. Obesity is a chronic metabolic disease
which is related to cardiovascular disease, diabetes or cancers. As a result,
people generally hold negative attitudes when they consider the role of
adipocytes in obesity.
Diabetes mellitus is another one common metabolic disease, which is
defined by the elevation of blood glucose level due to alteration of metabolism.23
3

Insulin plays key roles in regulating glucose homeostasis. Insufficient insulin
secretion or low sensitivity of insulin stimulation of the body can lead to
diabetes.23Patients with diabetes can be divided into two types: insulindependent type 1 diabetes (T1DM) and insulin independent type 2 diabetes
(T2DM). Diabetes has become prevalent in both developed and developing
countries. Take America as an example of the developed countries, the total
number of people diagnosed with diabetes has increased dramatically for the
past 40 years. The number of patients with diabetes is expected to increase 50%
by 2030.23 Take China as an example of the developing countries, based on the
current trend, the number of patients with diabetes is expected to nearly double
by 2030.23 The rates of blindness, renal disease or cardiovascular disease
increase in those people who are diagnosed with diabetes. Glycemic control is a
term used to describe the ability of maintaining blood glucose levels under
normal ranges. The impaired glycemic control of patients with diabetes further
harms the body health of patients.23 Although more and more people begin to
focus on how to control the prevalence of diabetes, the roles of micronutrients in
diabetes have not been well studied.
Nutrients are necessary for the growth and development of organisms.
Macronutrients, such as carbohydrate, lipids, and proteins, provide the basic
energy need for maintaining the normal metabolic state in the body.
Micronutrients act as cofactors in metabolic pathways in the body. Vitamin A (VA)
is a family of compounds which have the biological activity of retinol. VA plays a
key role in the development of animals.24 Retinoic acid (RA) is an metabolite of
retinol. The major functions of VA are mediated by RA. First, VA is necessary for
the development of nervous system.24 Second, VA can also influence the
differentiation and proliferation of cells. For example, the differentiation of
epithelial cells can be influenced by VA status.24 Third, the visual cycle needs
retinal, an oxidized production of retinol.24
One key role of RA is to regulate gene expression. RA can bind to nuclear
receptors in the cell to regulate gene expression. Both retinoic acid receptors
4

(RARs) and retinoid X receptors (RXRs) can be activated by RA. RAR/RXR or
RXR/RXR heterodimers can bind to RA response element (RARE) located in the
promoters of target genes. Then, the gene expression can be regulated following
ligand binding. Recently, it has been shown that chicken ovalbumin upstream
promoter-transcription factor II (COUP-TF II) and hepatocyte nuclear factor 4α
(HNF4α) can also influence the expression of RA-regulated gene recently.25
In summary, glucose metabolism are important in the regulation of
metabolic homeostasis. Muscle and adipose tissues are critical to the regulation
of glucose metabolism. The roles of VA and its signaling pathways in the
regulation of muscle and adipocyte glucose uptake have not been revealed
completely. It is important to understand RA function because RA signals have
effects on both energy metabolism and glucose metabolism. The aim of this
thesis is to understand how RA can influence the glucose metabolism in both
skeletal muscle cells and adipocytes. The data shown in this thesis may help to
learn how to control the prevalence of diabetes and obesity worldwide.
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CHAPTER TWO
REVIEW OF THE LITERATURE ON VITAMIN A, INSULIN
SIGNALING, MUSCLE METABOLISM AND 3T3-L1 METABOLISM
2.1 Vitamin A
2.1.1 Discovery of Vitamin A
Nutrients are needed for the growth and development of humans and
animals. For our energy need, macronutrients, carbohydrate, protein, and lipids,
are metabolized to generate ATP. Micronutrients are vitamins and minerals that
are used as cofactors to regulate biomedical pathways and building blocks to
sustain the body health, respectively. The human body only needs small or trace
amount of micronutrients compared with a large amount of macronutrients. VA is
known as a micronutrient.
In 1881, G. Lunin showed that mice could not live when fed pure casein,
fat, sucrose, minerals and water. Interestingly, he found when fed whole dried
milk, mice grew well.26In 1906, F. C. Hopkins hypothesized that “minimal
qualitative factors” in the diet were essential for growth and survival.27McCollum
showed that the existence of an important fat-soluble factor in milk was
necessary for the growth and development of rats. He successfully proved that
an ether extract of alfalfa leaves or liver could improve growth of rats.28This
unknown fat-soluble nutrient was termed as “fat-soluble factor A”. Osborne and
Mendel further isolated and identified the fat-soluble factor. They successfully
subtracted the yellow oil from butter fat.29However, they failed to subtract active
substance from lard or olive oil.30 P. W. Boutwell hypothesized that yellow
pigment (β-carotene) of fat-soluble factor A can be converted to the active form
(VA or retinol).31 This hypothesis was proved by T. Moore in 1930.32 In brief, VA
is one important micronutrient which deserve to be understood.

6

2.1.2 Structure and Physical Characteristics of VA
Retinol is the major form of VA which possesses a hydroxyl group at C15.24 Retinoids are a big family of compounds that have a 20-carbon structure
with a β-ionone ring and an isoprenoid side chain containing different chemical
groups at the acyclic terminus.24 Retinol can be oxidized to retinal which
possesses an aldehyde group (-CHO) at the acyclic terminus. Retinol and retinal
can be interconverted. RA can be generated in the body by two oxidation steps in
a sequence which convert retinol to retinal, and then, to RA. Once RA is
produced, it cannot be reduced back to retinal. RA possess a carboxylic acid
group (-COOH).24VA possess double bonds which are not stable. VA is soluble in
ethanol but almost insoluble in water. It can be freely solubilized in organic
solvents such as fats and oils. The side chain bonds of retinoids and carotenoids
can go through slow conversion between cis-form and trans-form. Light, heat,
and iodine can stimulate this conversion. Although retinol has a variety of
isomers, carotenoids present almost exclusive in the all-trans form in both plants
and animals. Most forms of VA are crystallizable but with low melting points. For
example, the melting point of retinol is between 62-64ć. VA and provitamin A
carotenoids are very sensitive to oxygen, light, and heat. It is important to
exclude air and add antioxidant when isolating VA and provitamin A
carotenoids.24
2.1.3 VA Sources
VA is an essential fat-soluble micronutrient because animals cannot
synthesize it. For humans and animals, it should be taken from foods. Dietary VA
exists in two forms: provitamin A carotenoids and preformed VA.24 Provitamin A
carotenoids are acquired from plant sources, while preformed VA retinyl esters
(REs) and retinol are derived from animal products.24 The main sources of
provitamin A carotenoids are fruit and vegetables. Lots of orange, dark green
colored fruits and vegetables are rich in carotenoids. Representative vegetables
and fruits of provitamin A include carrots, pumpkin, winter squash, and apricots,
etc. Carotene has 3 isomers: α-carotene, β-carotene, and γ-carotene.24 β7

carotene is one type of carotene which can be converted to functional VA in the
body. Cryptoxanthins is also one type of carotene which only possess half of the
biological activity of β-carotene.24 Preformed VA is commonly provided by foods
of animal products such as liver, dairy products, and fish.24 The best way to get
enough VA is to ingest a broad type of food.
It is important for us to ingest suitable amount of VA for our body health.
The international unit (IU) was used to measure VA activities in the past. VA has
different forms which make it complex to be measured in diet. People try to use
retinol as a common standard form of VA when measuring total amount of VA
content in diets. The amount of every types of VA needs to be transferred to the
amount of retinol. In brief, retinol activity equivalent (RAE) was set up to measure
amounts of VA sources. One RAE is equal to 1 microgram (mcg) of retinol. Take
carotene as an example, 2 mcg of β-carotene in diet or supplement is equal to 1
RAE. The Recommended Dietary Allowances (RDAs) for VA is 900 mcg RAE for
male and 700 mcg RAE for female between age 19 to 50 according to the
Institute of Medicine (IOM) in America.33
2.1.4 VA Uptake and Secretion
Different forms of VA in diets are absorbed. In the small intestine,
enterocytes can uptake carotenoids via passive diffusion. The provitamin A
carotenoids taken into cells are cleaved into retinal via two mechanisms: central
cleavage and eccentric cleavage. Both mechanisms work together to convert
carotene into retinal, which is reduced into retinol. In Figure 1, in the central
cleavage mechanism, 15,15’ carbon double bond can be cleaved by β, βcarotene-15, 15’-monooxygenase to generate two retinals.34 In the eccentric
cleavage mechanism, β, β- carotene-9’, 10’-dioxygenase catalyze carotenoids to
generate two molecules of β-apocarotenals with different molecular weights.34
Intestinal retinal reductase works later to reduce retinal to retinol.34Retinol and
RE are absorbed differently. RE can be hydrolyzed to retinol and FAs by
enzyme in intestinal lumen, which are then absorbed by the enterocytes. Two
enzymes have been identified in the hydrolysis process: intestinal brush border
8

Figure 1 VA Absorption, secretion and portal circulation in body.The animal source of
retinoids is RE. The plant sources of retinoids are carotenoids. Both RE and carotenoids can be
converted to retinol in intestine. Retinol is esterified to RE by enzymes in enterocytes of small
intestine. RE can be packed in chylomicrons which can be later secreted to the lymph circulation
to enter the general circulation. Chylomicrons can be converted to chylomicrons remnants after
several modifications of lipid components and lipoproteins. Liver parenchymal cells play a key
role in VA storage. Chylomicrons remnants are taken by liver parenchymal cells. RE can be
hydrolyzed to generate retinol which can be transported to endoplasmic reticulum to bind with
retinol-binding protein (RBP) in parenchymal cells. ROL- RBP later can be secreted to the blood
vessel or taken by the perisinusoidal stellate cells. In stellate cells, it can be stored in the form of
RE and release in the form of ROL- RBP complex to help maintain the homeostasis of plasma
ROL level between 1-2uM.
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enzyme phospholipase B and pancreatic triglyceride lipase. Then retinol was
taken up by the enterocytes.34
In the small intestine, after retinol is taken by the enterocytes, it can bind
to retinol-binding protein type II (CRBP-II). This protein helps to solubilize retinol
and to prevent its degradation. Long chain FAs and most retinol re-esterified later
to generate RE. This process is catalyzed by retinol acyl transferase (LRAT) in
enterocytes. Newly made RE can be incorporated in chylomicrons which carry
different VA molecules such as carotenoids, RE, retinol, etc. They are packed
together with triacylglycerol and phospholipids. Those chylomicrons are secreted
in the lymph duct to enter circulation process eventually.34(Figure 1)
2.1.5 VA transport and storage
After chylomicrons are secreted in the lymph system, they eventually enter
the general circulation system in the body. Hydrolysis of triacylglycerol and
exchange of apolipoproteins help to generate chylomicron remnants.
Chylomicron remnants with RE arrive at the liver via blood capillary. Although
tissues can extract most lipids and some carotenoids from circulating
chylomicrons, most RE are derived from the chylomicron remnants. Liver
parenchymal cells can basically uptake chylomicron remnants. Another type of
liver cell which is important for VA metabolism and storage is perisinusoidal
stellate cell. Parenchymal cells are responsible for the clearance of chylomicron
remnants with RE. RE is hydrolyzed in parenchymal cells again to generate free
retinol and FA. If retinol is not needed immediately in the cells, it can be reesterified in the perisinusoidal stellate cells and retained in it. Most retinol in
perisinusoidal stellate cells present in the form of RE packaged together with lipid
droplets. The storage mechanism of VA in the liver helps to maintain normal
plasma retinol level which is at1-2 uM. Stored RE can be hydrolyzed again by
hepatocytes. The released retinol binds with retinol binding protein 4 (RBP4) to
be released. RBP4 is mainly located in the ER of hepatocytes. RBP4 possesses
the ability to bind with free retinol to form a stable RBP-retinol complex. RBP10

retinol complex can translocate to Golgi apparatus before the complex is
secreted in plasma.35
After the RBP-retinol complex is secreted into the plasma, it can further
bind with transthyretin. Transthyretin is a larger protein synthesized and secreted
by hepatocytes. It interacts with thyroid hormone T4 and mediates T4 transports
in the blood. The larger transthyretin-T4-RBP-retinol complex can be recycled by
the kidney, a process that prevents the loss of retinol in the urine. This complex
circulates in the blood to deliver the lipophilic retinol to extrahepatic cells. The
complex can release transthyretin-T4 to form RBP-retinol complex again in
plasma. In the extrahepatic cells, RBP4 receptors on cell membrane can bind
with RBP-retinol complex. As a result, retinol can be taken by the target cells.35
2.1.6 Generation of Retinal and Retinoid Acid in Nonvisual Cells
Retinol can be taken directly from plasma and converted to the active
metabolites to exhibit multiple physiology functions inside target cells. In addition
to the retinol from the bloods, cells can also generate active retinoid metabolites
from those VA sources stored directly inside them or in the neighboring cells.
All-trans RA is the main active retinoid metabolite which is a ligand for the
activation of a transcriptional factor. RA can be generated from retinol in two
oxidation steps. all-trans retinol is converted to all-trans retinal first. This step is a
rate limit step.35 In the second step, all-trans retinal can be further oxidized to alltrans RA. Cytosolic medium-chain alcohol dehydrogenases (ADH) such as
ADH1, ADH3 and ADH4 play a key role in the first oxidation step. ADH4 is the
most efficient one. However, it seems that ADHs cannot catalyze the first
oxidation step if retinol is bound to CRBP-I.24Membrane-bound short-chain
dehydrogenase/ reductase (SDR) is also important for the first oxidation step.
SDR family of microsomal enzymes such as RDH1, RDH5 and RDH11 oxidize
all-trans retinol to all-trans retinal.36 SDR can use all-trans retinol even it is bound
to CRBP-I.29Retinal dehydrogenases (RALDHs) are responsible for the second
oxidation step. For example, RALDH2 oxidizes all-trans retinal to all-trans RA in
several cell types during embryonic development. 24
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2.1.7 VA Assessment, Deficiency and Toxicity
The standard of VA level in the human body is not easy to be established.
There are lots of potential influencing factors such as culture, geology, and
individuals.37 To assess different VA status in the body, plasma retinol and blood
RBP4 levels are widely used as indicators of VA status. Currently, VA sufficiency
is defined as a plasma retinol level > 1.05 umol/L. VA deficiency is defined at
retinol level < 0.7 umol/L. Mass spectrometry (MS) is used for testing plasma
retinol levels in the research and clinical labs nowadays. The relative dose
response (RDR) test is another method to determine the VA status in the human
body. In the first step, intravenous serum retinol concentration is measured. Next,
1000 mcg of retinyl palmitate is injected intravenously. Five hours later,
intravenous blood retinol level is measured again. When liver VA content is less
than 20 mcg/g liver, RDR values found are greater than 20%. When liver vitamin
A content is greater than 20 mcg/g liver, RDR values found are less than 10%.37
Different VA statuses have considerable influence on the body health of
human being. Both VA deficiency and VA toxicity (known as hypervitaminosis A)
have negative effects on lots of physiology processes in the body. VA deficiency
is not common in developed countries because people always ingest enough
amount of meat products. However, VA deficiency is prevalence in developing
countries. Take the data of children as an example, over one million children are
affected by VA deficiency worldwide.38 Low frequency and an insufficient amount
of diary and meat products consumption in meals can be used to explain why VA
deficiency is prevalence in developing countries.38VA toxicity is commonly found
in people with liver dysfunction typically. Other probable reasons leading to VA
toxicity include drug effect, and malnutrition.39 Absorption of excessive amount of
preformed VA can lead to VA toxicity, which is not the case of over consumption
of provitamin A carotenoids.39
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2.2 Retinoic Acid Signaling in the Regulation of Metabolism
2.2.1 Overview
Obesity and T2DM are two prevalent chronic metabolic diseases
worldwide. These diseases are associated with abnormal glucose and lipid
metabolism. This is in part attributed to the alteration of the expression levels of
genes in metabolic active tissues. VA metabolism is possible to influence the
macronutrient metabolism.24RA can regulate glucose and lipid metabolism.25This
is through the control of gene expressions, which includes those genes for the
glucose and lipid metabolism. The classic RA signaling system is mediated
through the binding of RA to transcription factors such as RARs and RXRs in the
nucleus, two family members of nuclear receptors.41Additional nuclear receptors
have been shown to mediate RA signaling.41HNF4α and COUP-TFII have been
thought to act as a nuclear receptor that can mediate RA signals to regulate gene
expression. RXRs, COUPTFII and others may play roles in mediating RA signals
in metabolic active cells. We believe that RA signaling and these transcription
factors may influence cellular metabolism which is associated with obesity and
T2DM.41
2.2.2 Nuclear Receptor
Lipophilic molecules like RA regulate cell differentiation, gene expression
and general physiology processes through the modulation of the activities of
nuclear receptors. Nuclear receptors interact with DNA sequences in the
regulatory regions of their target genes. The expression levels of target gene can
be regulated by nuclear receptors. Ligands bind to the nuclear receptors and
cause the conformation changes. The allosteric change results in recruitments of
other transcription factors for suppression or expression of the target genes. A
typical nuclear receptor protein is shown in Figure 2. The DBD allows the
receptors to bind to response elements on DNA. The conformation of
transcriptional activation domain can be changed after binding with ligands. The
LBD can bind to different ligands such as FAs, RA and steroids. Additionally,
another term called nuclear orphan receptor is used specifically to describe those
13

Figure 2 Common Structure of Nuclear Receptor. A typical nuclear receptor molecule
commonly contains five domains: N-terminal domain, DBD domain, hinge region, LBD domain
and C-terminal domain.
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nuclear receptors whose physiological ligands have not been identified. Although
the ligands of nuclear orphan receptors are not identified, they still interact with
specific elements on DNA. As a result, nuclear orphan receptors are still able to
up- or down-regulate target gene expression.42
RA can bind to RARs or/and RXRs nuclear receptors to form a complex
with changes of conformations. This RA and nuclear receptor complex are
associated with the specific DNA sequence called RARE. This binding complex
also interacts with other proteins in the genes’ promoters to regulate gene
expression. The cloning and identification nuclear receptors mediating RA
signaling systems have helped to understand RA signaling pathways.42
2.2.3 Retinoid X Receptors
Retinoids are important for cell growth, cell differentiation and nervous
system development, etc. Complex signal pathways help to explain the diverse
regulatory functions of retinoids. The first identified class of nuclear hormone
receptors is RARs. RAR has three isoforms, RARα, RARβ and RARγ. RARs can
bind with all-trans RA with high affinity. They share high level of structure
conservations.43
RXRs possess different basic structure and specific ligands compared
with RARs. RXRs cannot bind with all-trans RA. 9-cis RA is identified to be the
first ligand of RXR.44 The identification of RXR and its ligand (9-cis-RA) facilitate
the development of nuclear receptor area. First, it encourages researchers to
identify the ligands of orphan nuclear receptor. Second, it encourages people to
identify the nuclear receptors which can form heterodimers with RXRs.45 For
example, Peroxisome proliferator-activated receptor (PPAR) was proved to be
the first class of orphan nuclear which can heterodimerize with RXR. RXRs can
not only bind with RARs to form RAR/RXR heterodimers, but also bind with
RXRs or other nuclear receptors to form varieties of homodimers or
heterodimers. They can regulate transcription of target genes after binding to
RARE which located in the promoters of target genes.45
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RXRs can regulate the expression of genes involved in VA metabolism
because RXRs are expressed in a variety of metabolically active organs such as
small intestine, liver, and kidney.46 For example, CRBPII gene is a potential
target gene of RXRs. RXRs are also important for energy metabolism in mice.
For example, the expression of carnitine palmitoyl transferase I gene increased
in diabetic rat treated with LG100268 which is an RXR-specific agonist.47
Moreover, RXR-selective agonists can induce adipose differentiation in
preadipocytes. Mice with specific deletion of RXRα in hepatocytes show a lower
amount of food intake and higher body weight with increased glucose tolerance
than their controls.42 RXRα is also proved to be related with lipogenesis. For
example, in adipocytes, deletion of RXRα results in the resistant to obesity of
mice.42
2.2.4 The Chicken Ovalbumin Upstream Promoter-Transcription Factors
COUPTF II is one transcriptional factor that can influence the expression
of RA-regulated gene.25DNA sequences, regulatory factors and RNA polymerase
can interact with each other to modulate gene expression at transcription level.
Both recombinant DNA and gene transfer techniques help to characterize the
promoters for RNA polymerase II-transcribed gene. Both cis-acting elements in
DNA and the regions located further upstream in DNA are necessary to initiate
DNA transcription. Experiments were conducted to test initiation efficiency of
DNA transcription. Take the ovalbumin gene as an example, the TATA box is
one of the cis-acting DNA elements which is located between -24 to -32 base
pairs from the initiation site of the transcription. The efficiency and accuracy of
DNA transcription initiation is supported by the TATA box. CAAT box which is a
specific upstream sequence from TATA box is also necessary for initiating
transcription of genes with high efficiency. CAAT box contains direct repeat of
GTCAAA sequence which is located around 80 base pairs away from the cap
site. The cap site located on a DNA template where transcription begins. The
result of 5' deletion mapping method first proved the existence of a distal DNA
element in the promoter. Transcription competition assays were performed to test
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the existence of a potential transcription factor that can interact with the promoter
element. As a result, it is proved that CAAT box was an important DNA sequence
which can bind with a transcription factor. To further identify a specific protein
which can bind to CAAT box in ovalbumin gene, exonuclease footprinting
experiments were conducted. In conclusion, a specific type of transcription
factors called COUP-TFs were identified. COUP-TFs can bind with the direct
repeat of GTCAAA sequence in the upstream promoter region of the ovalbumin
gene.48
COUP-TFs include COUP-TFI, COUP-TFII and COUP-TFIII.25 COUP-TFs
are still orphan nuclear receptors, which have been studies extensively. All of
them belong to the NR2F subfamily of nuclear receptors.25 COUP-TFII plays a
key role in embryonic development and can influence the reproductive function of
mice. During embryonic development, COUP-TFII gene (Nr2f2) is widely
expressed in tissues and organs of mice. COUP-TFII homozygous knockout
(Nr2f2−/−) mice had defection in heart development.49COUP-TFII can also
regulate insulin synthesis and secretion in pancreatic β-cells. Higher amount of
insulin is required to keep the stable of glucose level for those people with low
insulin sensitivity. In general, low insulin sensitivity indicate the abnormal
metabolism of glucose in body. Impaired insulin sensitivity, abnormal insulin
secretion and insulin resistance were found in mice specifically deleted of Nr2f2
in pancreatic β-cells.50

2.3 Insulin Signaling and Glucose Transporters
2.3.1 Discover of Insulin
The discovery of insulin led to its use for the treatment of diabetes
mellitus. In 1893, the link between pancreas (an organ) and diabetes (a
metabolic disease) was established through the research work by Oskar
Minkowski and Joseph von Mering.51 In the beginning of the first two decades of
the twentieth century, people failed to extract functional substance from pancreas
for the treatment of diabetes. This special substance was believed to be able to
regulate blood glucose level in the body. Frederick G. Banting initiated attempts
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to extract components from dog pancreas to test its ability to control the blood
glucose level in diabetic dogs.52Banting and his team members successfully
extracted and purified insulin for the treatment of patients with diabetes and were
awarded the Nobel Prize.53 The studies of insulin and its action have led many
great discoveries and breakthrough in biomedical sciences. For example, the
determination of insulin amino acid sequence led to the development of method
for protein sequencing by Frederick Sanger.53
2.3.2 Insulin Synthesis
In pancreatic β-cells, insulin is synthesized as preproinsulin which
contains 110 amino acids. Preproinsulin is processed and secreted as mature
insulin with the C-peptide into the blood circulation. The secreted insulin exists as
a monomer to regulate metabolism through the binding to its receptor. It is stored
in the form of hexamers in the secretory granules of pancreatic β-cells. Monomer
form of insulin contains one A and one B chain. They are linked together by three
disulfide bonds. Two disulfide bonds link A chain with B chain, the other one is
located within A chain. For the secondary structure, A chain is made up of two
antiparallel α-helices while B chain is made up of both α-helices and β-sheets.54
In pancreatic β-cells, preproinsulin is first translated from mRNA
transcribed from insulin gene. Preproinsulin contains a specific N-terminal signal
peptide. Preproinsulin can later translocate from the rough endoplasmic reticulum
(RER) to the lumen. N-terminal signal peptide is cleaved to produce proinsulin in
the lumen of RER. Cleavage leads to the formation of disulfide bonds in
proinsulin and its folding. In trans-Golgi apparatus, proinsulin is further cleaved to
produce the active mature insulin and the C-peptide. This process is catalyzed by
cellular endopeptidases prohormone convertases and the exoprotease
carboxypeptidase E. As a result, mature insulin only contains A chain and B
chain. The mature insulin and C-peptide are packaged inside secretory
granules.54
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2.3.3 Insulin Secretion
In response to the ingestion of nutrients, insulin is released to control the
metabolic homeostasis. Glucose is the major stimulus of insulin secretion.
Digestion of starch, the main dietary component, results in absorption of glucose
and leads to the rise of blood glucose level. Maximal Velocity (Vmax) and
Michaelis constant (Km) are the two factors which help to explain the function of
GLUTs.55 Vmax is termed to describe the rate of catalyze reaction when
substrates fill up all the activity sites of GLUTs. Km is the concentration of
glucose at half of the Vmax. Glucose metabolism is needed for glucosestimulated insulin secretion. Glucokinase, also known as hexokinase D, is also a
high Km enzyme and is a rate-limiting step for glucose-stimulated insulin
secretion.55 Comparing with other type of hexokinase, hexokinase possesses
lower affinity for glucose. The Km of hexokinase is 6 mmol/L. The normal blood
glucose range is between 4 mmol/L to 10 mmol/L. Moreover, the function of
glucokinase cannot be suppressed by-products of this reaction, glucose 6phosphate. As a result, glucokinase only works at high glucose level to start
glycolysis.55 The high Km values of GLUTs and hexokinase D in pancreatic βcells ensure that insulin secretion only occurs when glucose concentration is
high. GLUT2 is a high Km glucose transporter expressed in pancreatic β-cells.
This allows that glucose only enters pancreatic β-cells when blood glucose level
is high.
The end product of glycolysis is pyruvate, which is further converted into
acetyl CoA in mitochondria. In the tricarboxylic acid cycle, acetyl CoA is oxidized
to generate ATP in the mitochondria of pancreatic β-cells. This pathway can
couple with the ATP-sensitive potassium channel-dependent pathway to
stimulate insulin secretion. The oxidation of pyruvate can lead to the increase of
ATP/ADP ratio. The ATP-sensitive potassium channel will be closed because of
the increase of ATP/ADP ratio. Then potassium ions (K+) is prevented from
leaving the cell. The accumulation of K+ can lead to the depolarization of the cell
membrane. Then voltage-sensitive calcium (Ca2+) ions channels open because
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of the accumulation of K+. When the concentration of Ca2+ accumulates to a high
level in pancreatic β-cells, insulin can be released.56
2.3.4 Insulin Signal Transduction
Insulin initiates its physiological actions through the binding to insulin
receptor on cell surface. Insulin receptor contains α-subunits and β-subunits,
which are linked by disulfide bonds. When insulin binds with the α-subunits, two
β-subunits come close to each other. The β-subunit of insulin receptor is a
tyrosine kinase, which can phosphorylate each other in close proximity. This
phenomenon is termed as autophosphorylation.56 The phosphorylated β-subunits
recruit insulin receptor substrates (IRS) and phosphorylate them. Phosphorylated
IRSs can recruit additional signal transduction components and activate a signal
cascade which mediates insulin signal transduction.56
The phosphatidylinositol 3’-kinase(PI3K)-Akt signaling pathway (PI3K/Akt)
are important in mediating insulin signal.(Figure 3) Serine/threonine kinase
Akt/PKB is one important enzyme in this pathway. Phosphatidylinositol 3’-kinase
(PI3K) can convert phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to
phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P3). This is important for insulin
action. PI3K is made of two subunits: P110 and P85. P110 is a catalytic subunit
while P85 is the regulatory subunit. PI3K can be activated by both receptors with
protein tyrosine kinase activity and G protein-coupled receptors (GPCR).
Pleckstrin homology (PH) domain can mediate the effect of PIP3. Akt is a
serine/threonine kinase. Production of PI(3,4,5)P3 leads to the activation of Akt.
Akt includes PH domain, a kinase domain, and regulatory domain. PH domain of
Akt can interact with PIP3. As a result, the conformation of Akt changes. Thr308
and Ser473 of Akt are phosphorylated. Phosphatidylinositol-dependent protein
kinase 1 (PDK1) are important for the activation of Akt. It can phosphorylate
Thr308 in the kinase domain of Akt which helps to stabilize the conformation of
Akt. Phosphorylation of residues in C-terminal region is also necessary to fully
activate Akt.57(Figure 3)
Insulin can also activate the Ras-Mitogen activated protein kinase (MAPK)
20

Figure 3 Phosphatidylinositol 3’-kinase(PI3K)-Akt signaling pathway (PI3K/Akt).
Phosphoinositol 3’-kinase (PI3K) converts PI(4,5)P2 to PI(3,4,5)P3. PI3K is made up of two
subunits: P110 and P85. P110 is the catalytic subunit. P85 is the regulatory subunit. PI3K can be
activated by either receptors with protein tyrosine kinase activity or G protein-coupled receptors
(GPCR). Pleckstrin homology(PH) domain mediate the effect of PIP3. PI(3,4,5)P3 by PI3K leads
to the activation of Akt. PH domain of Akt can interact with PIP3 which leads to the conformation
of Akt changed. Thr308 and Ser473 are phosphorylated.
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pathways as well. Ras belongs to the family of GTPases. Ras can bind to
guanosine triphosphate (GTP) as well as hydrolyze GTP. As a result, GTP/
guanosine diphosphate (GDP) exchange rate can be regulated. The Ras–MAPK
pathway is activated by insulin first. Then growth factor receptor-bound protein 2
(Grb2) and the guanyl nucleotide-exchange factor Son of Sevenless (SOS) come
to cognate with IRS proteins, SHC-transforming protein (Shc) and GRB1associated-binding protein (Gab1).58 Raf is activated to trigger a pathway in
which the dual-specificity kinases MEK1 and MEK2 are activated. Dual-specificity
kinase is a term used to describe a kinase which possesses characteristics of
both tyrosine kinase and serine/threonine kinase. Dual-specificity kinase MEK1
activates downstream MAPK such as ERK.58
2.3.5 Glucose Transporters (GLUTs)
The concept of glucose transporters appeared in 1948 when it was found
that glucose could not pass through the cell membrane freely. 59 GLUTs are
membrane proteins. They can mobolize glucose through the cell membrane.
Based on the molecular cloning results, a total of 14 GLUTs have been identified
in the human genome. All of them are encoded by the members of soluble carrier
family 2 (SLC2) gene family. All GLUTs have near 500 amino acid residues
arranged in a 12 membrane-spanning helical structure. As described in Figure 4,
there is an N-terminal glycosylation between transmembrane helices 1 and
transmembrane helices 2.59

Figure 4 Structure of glucose transporters. Glucose transporters contain 12 transmembrane
helices with N-terminal and C-terminal. There is an N-terminal glycosylation between
transmembrane helices 1 and transmembrane helices 2.
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GLUT4 is an insulin-stimulated glucose transporter which is encoded by
SLC2A4 gene in humans.17 Insulin can regulate both the expression of GLUT4
and the translocation of GLUT4. GLUT4 is one of the most well studied types of
GLUT. GLUT4 can transport glucose, glucosamine and dehydroascorbic acid
(DHA) to cross the membrane. GLUT4 is important in glucose metabolism and
glucose homeostasis. The impairment of GLUT4 regulation is associated with
chronic diseases, such as obesity and T2DM. In the skeletal muscle, exercise
helps to improve insulin sensitivity as well as stimulates the express of SLC2A4
gene at transcription level.60
In general, the substrate binding site of GLUTs can be identified in amino
acid residues located on both outside and inside of the cell membrane. The
transport of glucose by GLUTs is bi-directional. The binding of glucose to GLUTs
will lead to the conformation change of GLUTs. Glucose can be released on the
other side of the membrane as a result. In insulin-responsive tissues, insulin can
stimulate the translocation of GLUT4. As described in Figure 5, GLUT4 is
distributed major in tubulo-vesicular structures, an intracellular structure. GLUT 4
can be sequestered to the plasma membrane via exocytosis and recycle back to
the tubulo-vesicular structures via endocytosis. GLUT4 vesicles arrive on the
plasma membrane first and then fuse with the membrane. Insulin stimulates the
exocytosis rate of GLUT4. Exocytosis rate of GLUT4 can be increased by 2.8
folds when stimulated by insulin. The endocytosis will continue with or without
insulin. GLUT4 is recycled by clathrin-coated vesicles, which prepares to be
sorted and sequestered again via exocytosis.60

2.4 Skeletal Muscle Cells
2.4.1 Physiology Role of Skeletal Muscle
In adults, the muscle makes up to nearly the half of the human body mass.
There are mainly three types of muscle: skeletal muscle, cardiac muscle, and
smooth muscle. Cardiac muscle is a type of involuntary striated muscle found in
the heart. Cardiac muscle plays a key role in maintaining the rhythmic
contractions of the heart.61 Contractions pump the blood from the heart to the
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Figure 5 Translocation of glucose via GLUT4. GLUT 4 is present in intracellular tubulovesicular structures with no existence of insulin. Exocytosis rate is increased after insulin
stimulation. GLUT 4 can be sequestered to the plasma membrane via exocytosis and recycle
back to the tubulo-vesicular structures via endocytosis. GLUT 4 vesicles arrive in the plasma
membrane first and then fuse with the membrane. Insulin has considerable influence on the
exocytosis rate of GLUT 4. Exocytosis rate of GLUT 4 can increase to 2.8 folds when stimulated
by insulin. The endocytosis will continue with or without insulin. GLUT 4 is recycled by clathrincoated vesicles and sorted and sequestered again via exocytosis.
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rest part of the body. Smooth muscle is an involuntary non-striated muscle which
is different from skeletal muscle and cardiac muscle. It is found in the walls of an
internal organ or in the tracts of digestive/reproductive system. Smooth muscle
contracts automatically with a lower speed compared with striated muscle.
Skeletal muscle is a voluntary striated muscle which is connected by connective
tissue. It is the most common type of muscle distributed in the human body. 61
Sarcolemma is a term used to describe the cell membrane of a skeletal
muscle cell.61 Muscle fibers include myofibrils that are made up of sarcomeres. In
the cytoplasm, fibers are assembled as a striated pattern contain thick and thin
filaments that form myofibrils. The thick filaments are mainly composed of the
protein myosin. The thin filaments are mainly composed of actin, troponin and
tropomyosin. These proteins and other necessary factors like calcium work
together to activate cross-bridges, which leads to the contraction of muscle.
Skeletal muscle plays important roles in lots of physiology functions in the human
body. The essentiality of skeletal muscle is associated with body movement and
body gesture maintenance. Additionally, skeletal muscle is important for
supporting the function of digestive and urinary systems. For example, sphincters
are made up of skeletal muscle. Sphincters can support swallowing and
urination. Moreover, skeletal muscle helps to regulate the body temperature.
Contraction of skeletal muscle can lead to the generation of heat which helps
body to maintain a constant body temperature.61
2.4.2 L6 Rat Skeletal Muscle Cells(L6 cells)
L6 rat skeletal muscle cells (L6 cells) were originally derived from thigh
tissue of baby rat. It was first isolated and established by David Yaffe in 1965. 62
Primary skeletal muscle cultures were used to establish L6 rat cell line. The
recipe of culture medium was medium 199(22.5%) and Dulbecco's modified
Eagle medium (67.5%) containing horse serum (10%) and chick embryo extract
(1-3%). Cells were kept in humid incubator at 37°C and 10% CO2. Next, several
passages of myoblasts were conducted to select those cells which can attach to
the plate. Clonal cells were isolated. As a result, L6 cell line was successfully
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established.63 In 1970, Yaffe proved that L6 cells can still maintain their
myoblastic shape and can be differentiated to fuse with multinucleated fibers
under standard culture conditions.63
The differentiation of skeletal muscle from myoblasts into myotubes
completes by birth. Then only the size of muscle fiber can change in adults. It
was proved that L6 cells present high differentiation rate when the basal medium
containing high serum level is changed to a medium containing low level of horse
serum (2%).64 Under some specific conditions when muscle is damaged, muscle
satellite cells begin to proliferate as myoblasts. Newly formed myoblasts can
further differentiate and fuse into myotubes. This process is termed as muscle
regeneration. Muscle regeneration is activated by the inflammatory response
which is caused by the muscle damage.65 Take the proinflammatory monocytes
as an example, they can differentiate into proinflammatory macrophages in the
damaged site. Then proinflammatory macrophages become M1 macrophages
when muscle is damaged. M1 macrophages can secrete cytokines which can
activate satellite cells to facilitate the differentiation and fuse of myoblasts into
myotubes(Figure 6).55
Several important studies have been done using L6 cells as a research
model. L6 cells have been used for studying the proliferation and differentiation
of myogenic cells. In 1989, it was proven that growth factors and hormones could
influence the proliferation and differentiation of L6 skeletal muscle. 66 L6 cells are
used to study the influence of insulin on glucose utilization. It has been shown
that insulin treatment for 24 h can lead to up to 10-fold activation of glucose
transport activity after glucose deprivation.67 In summary, L6 cells are a good
model for studying the cell proliferation, cell differentiation, and glucose
metabolism.
2.4.3 The Role of Skeletal Muscle in Glucose/Glycogen Metabolism.
Skeletal muscle plays a key role in glucose metabolism. Glucose and fat
are the basic energy sources of skeletal muscle. During exercise and physical
activities, glucose uptake is necessary to provide energy for skeletal muscle.
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Figure 6 Skeletal muscle differentiation and regeneration. When muscle is damaged, muscle
satellite cells begin to proliferate as myoblasts. Newly made myoblasts can further differentiate
and fuse into myotubes. This process is termed as muscle regeneration. Muscle regeneration is
activated by the inflammatory response which is caused by the muscle damage. Take the
proinflammatory monocytes as an example, they can differentiate into proinflammatory
macrophages in the damaged site. Then proinflammatory macrophages convert into M1
macrophages when muscle is damaged. Cytokines can be secreted by M1 macrophages to
facilitate the differentiation and fuse of myoblasts into myotubes.
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Glucose uptake is also important for the storage of glycogen in muscle
afterexercise. Skeletal muscle, liver, and pancreatic β cells cooperate with each
other to control the blood glucose level in a narrow range from 4.0 to 5.9 mmol/L
in healthy subjects.13 Any defect in skeletal muscle, liver and pancreatic β-cells
will lead to some problems in glucose homeostasis in the body. For example, the
decrease in muscle cell number and impaired function of muscle cells have
negatively influence on whole body glucose homeostasis in mice.17
Insulin regulates glucose and glycogen metabolism in the skeletal muscle.
The sensitivity of muscle in responsive to insulin is important in maintaining
normal glucose level. Glucose transport is a rate-limiting step in glucose
metabolism.17 Insulin can stimulate the movement of a GLUT4 from intracellular
poor to the plasma membrane. GLUT4 locates specifically in cells of the striated
muscle and adipose tissue. They can move rapidly from the intracellular storage
locations to the plasma membrane when cells are stimulated by insulin. Once
present on the cell membrane, GLUT4 begins to mediate the uptake of glucose
into the skeletal muscle cells. The decreased responsiveness of tissues including
skeletal muscle to the circulating insulin is termed as insulin resistance. Skeletal
muscle insulin resistance is prevalent in patients with diabetes. Skeletal muscle
insulin resistance generally begins in a small part of muscle mass. When skeletal
muscle resistance develops to a significant percentage of muscle mass,
disturbance of glucose homeostasis shows up. In T2DM patients, skeletal muscle
resistance is the key reason to cause glucose homeostasis disturbance. Insulin
resistance is specifically harmful to the early stage diabetes individuals. At the
late stage, T2DM diabetic patients typically suffer from decreased insulin
secretion and insulin resistance.13

2.5. Adipocytes
2.5.1 Adipocytes and Adipogenesis
Adipose tissues are mainly consisted of adipocytes and found under the
skin, between muscles and surrounding organs. There are two types of adipocyte
tissues in mammals: white adipose tissue (WAT)19 and brown adipose tissue
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(BAT).20 WAT is the most common type of adipose tissue. WAT can protect
organs as well as provide energy under conditions like starvation. Lipolysis is a
term used to define the triacylglycerol hydrolysis mediated by lipases, a process
that generates FAs and glycerol. FAs can be oxidized in mitochondria for energy
production in other tissues. The hydrolysis of triacylglycerol can be activated by
hormones such as epinephrine, glucagon, etc. WAT is not a simple site for
energy storage; it exhibits endocrine functions through secreting cytokines such
as adiponectin, leptin, and resistin.19 These cytokines also called adipokines,
which play key roles in energy metabolism.19 BAT is another type of adipose
tissue responsible for heat production due to the presence of abundant
mitochondria in brown adipocytes. BAT is generally found in new born animals.20
The portion of BAT decreases with the increase of age in human.20
Adipogenesis, the growth and differentiation of adipocytes, has become a
hot topic in recent years. The major health problem related to adipogenesis is
obesity. There are several conversion stages from fertilized egg to mature
adipocyte. A shown in Figure 7, fertilized eggs possess the ability to differentiate
into different cell types. The stem cells which possess mesodermal origins can
differentiate to preadipocytes.68 In the late stage of embryonic development in
human, preadipocytes begin to differentiate into adipocytes.69 On the other hand,
rat preadipocytes cannot begin to differentiate into adipose tissue until after
birth.70

Figure 7 Differentiation process from a fertilized egg to mature adipocyte. There are several
conversion stages from fertilized egg to mature adipocyte. Fertilized eggs can differentiate into
different cell types. The stem cells which possess mesodermal origins can differentiate to
preadipocytes. Preadipocytes can further differentiate into adipose tissue.
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Adipose tissues possess key roles in controlling whole-body metabolism.
The lack of adipose tissue mass leads to the increased circulating concentrations
of triacylglycerol and FAs in both mice and humans. The presence of adipose
tissue is necessary for normal secretion of adipokines such as leptin and
adiponectin.19 Both leptin and adiponectin can enhance insulin sensitivity. 19 The
secretion of appropriate levels of adipokines and storage of lipids contribute to
the function of adipose tissues in regulating whole body metabolism. Adipocytes
can synthesize and store triacylglycerol during feeding, and release FAs and
glycerol from hydrolysis of triacylglycerol during fasting.71
2.5.2 3T3-L1 CARΔ1 Adipocytes
3T3-L1 cells have been used as a cell model to study the differentiation
and physiology of adipocytes. It is a good model to study the transformation of
preadipocytes into adipocytes. 3T3-L1 cells were isolated from mice embryonic
cells. They have been used in biological research on adipocyte differentiation.
3T3 cells are cells that need to be subcultured every 3 days to inoculum 3×105
cells per well.72Before differentiation, 3T3-L1 cells grow like a fibroblast. These
cells can be differentiated into mature adipocytes under specific conditions. 3T3L1 preadipocytes can be induced to differentiation by a mixture of reagents
promoting abiogenesis under confluency state. The mixture of insulin,
glucocorticoid, and fetal bovine serum leads to the high differentiation rate of
3T3-L1 preadipocytes to adipocytes.73 MDI is an abbreviation to describe the
mixture of insulin, dexamethasone and methylisobutylxanthine (MIX).
Dexamethasone (DEX) is a glucocorticoid agonist which can activate the
pathways for glucocorticoid receptor. Mix is a cAMP-phosphodiesterase inhibitor
which is can activate the cAMP-dependent protein kinase pathway. 73
Preadipocytes begin to differentiate after the treatment with MDI.
Preadipocytes under differentiating status go through a postconﬂuent mitosis
stage after the induction with MDI for 24 hours.73Postconﬂuent mitosis plays a
key role in unwinding DNA. Transcription factors can bind with the regulatory
response elements in genes which modulate the phenotypes of mature
30

adipocytes as a result.73 Then, cells complete the postconﬂuent mitosis status to
enter a stage called growth arrest by day 2. Growth arrest stage is necessary for
continuing the differentiation process. Lipogenic enzyme, lipolytic enzymes and
important proteins begin to be expressed in differentiating cells. Those expressed
proteins are important for modulating the phenotypes of mature adipocytes. By
day 5 to day 7, the shape of cells becomes round and lipids begin to accumulate
in cells.74
3T3-L1 cells are also used to study growth control and action of oncogenic
viruses.75 It is important to understand the mechanisms related to adipocyte
conversion and lipid homeostasis. Analysis of the expression profiles of
exogenous proteins in 3T3-L1 cells helps to study the proteins functions in
adipose tissue. Coxsackievirus and adenoviruses are human pathogens.
Coxsackie B viruses are members of the picornavirus family which are nonenveloped RNA viruses.75 Adenoviruses can cause infections in respiratory and
gastrointestinal systems. Adenoviruses are non-enveloped DNA viruses.
67Recombinent

adenovirus has been considered as a useful tool for introduction

of exogenous genes into cells. However, 3T3-L1 cells cannot be transfected
effectively by recombinant adenovirus.76 There are generally two methods to
increase the infection efficiency: modifying the viral particles of adenovirus or
modifying gene expressions of 3T3-L1 cells. It is relatively convenient to modify
gene expressions in 3T3-L1 cells. Coxsackie and adenovirus receptor (CAR) can
bind with a protein of adenovirus to initiate the viral infection process. The
efficiency of infection or transduction can increase significantly if CAR is
expressed exogenously in Chinese hamster ovary cells. 77 The cytoplasmic tail of
CAR is not necessary for the transfection of adenovirus. CAR was modified by
deletion of the cytoplasmic tail, CAR Δ1 construct. CAR Δ1 expression construct
was transfected into 3T3-L1 cell. 3T3-L1 cells with the expression of CAR Δ1 is
termed as 3T3-L1 CAR Δ1 cells. The efficiency of transfection of recombinant
adenovirus in 3T3-L1 CAR Δ1 cells increased significantly comparing with that in
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parental 3T3-L1 cells while the accumulation of lipids did not change
significantly.75

2.6 Conclusion
Skeletal muscle and adipocytes play key roles in glucose metabolism and
energy homeostasis. VA and insulin may work together to regulate macronutrient
metabolism in cells. RA exhibits the major physiological functions of VA. We
aimed to find the influence of RA and insulin on the GLUT4 expression levels in
L6 muscle cells and 3T3-L1 CARΔ1 adipocyte. Understanding the mechanism of
how RA influences macronutrient metabolism will help us to better control
diabetes and obese.
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CHAPTER THREE
RA AND INSULIN INHIBIT THE EXPRESSION OF GLUT4 IN
DIFFERENTIATED L6 MUSCLE CELLS
3.1 Introduction
VA is a group of compounds which exhibit the biological activity of retinol.
VA is one fat-soluble micronutrient which plays key role in the growth and
development of animals.24 The major functions of VA are mediated by RA. RA
regulates many aspects of cell differentiation and proliferation. This is done via
regulation of the gene expression levels associated with these processes. RA
signaling pathway is mainly mediated by transcription factors in nuclear receptor
super family.42
Skeletal muscle is one important type of muscle, which contributes
significantly to glucose homeostasis. Depending on the metabolic states, skeletal
muscle can utilize either glucose or FA as an energy source. It can also store
glucose as glycogen or oxidizes it directly to generate energy under different
metabolic conditions after the uptake of glucose. 24 Skeletal muscle uses a
significant amount of glucose for energy production in physical activities.
Additionally, it also converts excessive glucose into glycogen for the use as a
quick source of glucose intracellularly.24 Therefore, understanding the muscle
glucose metabolism is relevant to the intervention of the development of
metabolic diseases, such as obesity or diabetes.
L6 muscle cells were established to study the muscle differentiation.62 As
a muscle cell line, L6 muscle cells have been used as a tool to study cell
proliferation, cell differentiation, and glucose metabolism. Several important
studies have been done using L6 cells as a research model. L6 cells have been
used for studying the proliferation and differentiation of myogenic cells. In 1989, it
was proven that growth factors and hormones could influence the proliferation
and differentiation of L6 skeletal muscle.66 L6 cells is a good model to study
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glucose utilization. It has been shown that a 24-hour insulin treatment can lead to
up to 10-fold activation of glucose transport activity in differentiated L6 cells after
glucose deprivation.67
There are only limited studies focusing on the effect of RA on glucose or
energy metabolism in L6 cells. RA possesses a key role in skeletal muscle
differentiation. Based on the studies before, pluripotent embryonic stem cells (ES
cells) can be cultivated under different conditions which lead to cardiogenesis or
myogenesis.78 In 1994, Victor Maltsev conducted an experiment to test the
effects of RA doses on ES cells.78 ES cells were incubated with 10−8 and 10−7
mole(M) RA. He found that cardiogenesis was inhibited while myogenesis was
induced between Day 2 and Day 5. He further observed that transcription of
skeletal muscle-specific myogenin was induced while transcription of cardiacspecific α- and β-cardiac myosin heavy chain (MHC) genes were inhibited.78This
result proved that RA is important in the differentiation process from ES cells to
skeletal muscle cells.
Glucose uptake is mediated by GLUTs in muscle cells. The impairment of
GLUT4 regulation is associated with chronic disease such as obesity and T2DM.
Insulin is the major stimulus for the increased glucose uptake and usage in
skeletal muscle after a meal. This process has been thought to be mediated by
the insulin-induced GLUT4 translocation.17 On the other hand; physical activities
also promote the translocation of GLUT4. Exercise increased the GLUT4 in
plasma membrane.79In the skeletal muscle; exercise helps to improve insulin
sensitivity as well as stimulates the expression of SLC2A4 gene at the
transcription level.60 Physiological factor like fiber type of muscle can also
influence the GLUT4 protein level. GLUT4 protein level is higher in red muscle
fibers than in white muscle fibers.80 Those results proved to us that GLUT4
protein level is a crucial factor in skeletal muscle glucose metabolism.
It is important to understand RA function because RA signals affect both
energy metabolism and glucose metabolism. The hypothesis of this thesis is that
RA and insulin have a synergistic influence on GLUT4 expression in L6 cells.
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Here, the GLUT4 expression in L6 cells treated with increasing doses of RA or
10 nM insulin for 6 days were tested. The effects of RA alone and in combination
with insulin on GLUT4 expression in L6 rat muscle cells were also tested in Day
4 and Day 6. Finally, the phosphorylation status of Akt and the expression levels
of GLUT4 in L6 cells following one-hour treatment with increasing concentrations
of insulin were checked.

3.2 Materials and Methods
3.2.1 Reagents
For L6 rat skeletal muscle cell culture and differentiation, Dulbecco's
Modified Eagle Medium (DMEM) was purchased from Mediatech (Manassas, VA,
U.S.A.). Fetal bovine serum (FBS) was purchased from Life Technologies (Grand
Island, NY, U.S.A.). Horse serum (HS) was purchased from Hyclone
Laboratories (Logan, UT, U.S.A.). Penicillin/Streptomycin(P/S) was purchased
from Mediatech (Manassas, VA, U.S.A.). To treat cells with insulin and RA,
insulin and all-trans RA and were purchased from Sigma Aldrich Corporation(St.
Louis, MO, U.S.A.). The bicinchoninic acid (BCA) protein assay kit was
purchased from Pierce Biotechnology, Inc (Rockford, IL, U.S.A.) to test the
protein concentration. Immobilon-PSQ PVDF membrane was purchased from
EMD Millipore Corp (Billerica, MA, U.S.A.). Non-fat dry milk of Food Club was
purchased from to a grocery store and was used to block membrane and to
dissolve the first antibodies (GLUT4, β-Actin, Akt, phospho-Akt, total Akt). Bovine
serum albumin (BSA) protease-free powder was purchased from Fisher
BioReagents™ to make the second antibody. For immunoblotting, GLUT4
antibody (C-terminus) was purchased from EMD Millipore Corp (Billerica, MA,
U.S.A.). β-Actin (#4970), total Akt (#9272), phospho-Akt (Ser473) antibodies and
horseradish-conjugated goat anti-rabbit IgG (#7074) secondary antibody were
purchased from Cell Signaling Technology (Danvers, MA, U.S.A.). ECL Western
Blotting Substrate was purchased from Pierce Pierce Biotechnology, Inc
(Rockford, IL, U.S.A.), which was used to visualize the recognized proteins.
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3.2.2 L6 Rat Skeletal Muscle Cell Culture and Differentiation
L6 cells were maintained in 60 mm dishes with DMEM with 4.5 g/L
glucose supplemented with 10% FBS + 1% P/S in the incubator at 37°C, 5% CO2
and 95% air. The medium was changed to DMEM containing 4.5 g/L glucose
with 2% HS + 1% P/S to induce differentiation when cells reached near 100%
confluence.
For the insulin dosage experiment (one-hour treatment), when cells
reached near 100% confluence, culture medium was changed to differentiation
medium (DMEM+ 2% HS + 1% P/S) for 6 days. Differentiation medium was
changed every 2 days. On Day 6, the cells were divided into five groups to be
treated with the differentiating media containing increasing concentrations of
insulin for one hour. The insulin concentrations were: (1) 0 nM, (2) 0.1 nM, (3) 1
nM, (4) 10 nM and (5) 100 nM insulin. Then cells were lyzed to obtain total
protein. After indicated treatments, L6 cells in 60 mm dishes were washed once
with 3 ml PBS and scrapped from the dish into 400 μl of whole-cell lysis buffer.
The lysates were placed on ice for at least 20 min before they were subjected to
centrifugation at 12000 x g for 20 min.
For the RA dosage experiment (4 or 6 days), when cells reached near
100% confluence, medium was changed to differentiation medium (DMEM+ 2%
HS + 1% P/S) containing (1) 0 μM RA, (2) 0.3 μM RA, (3) 1 μM RA, (4) 3 μM RA,
(5) 10 μM RA, (6) 0 μM RA+10nM Insulin, (7) 0.3μM RA+10 nM Insulin, (8) 1 μM
RA+ 10 nM Insulin, (9) 3 μM RA+ 10 nM Insulin, (10) 10 μM RA+10 nM Insulin.
Cells were treated for 4 days or 6 days. RA was dissolved in 200 proof ethanol to
prepare RA stock. The media were changed to fresh media every 2 days. At the
end of the 4-day or 6-day treatments, cells were lyzed and subjected for further
analysis by immunoblotting.
For the long-term RA and insulin experiment (4 or 6 days), when cells
reached near 100% confluence, medium was changed to differentiation medium
(DMEM+ 2% HS + 1% P/S) containing (1) 0 nM Insulin/0 μM RA (control group),
(2) 1μM RA, (3) 10nM Insulin or (4) 1μM RA/10nM Insulin. Cells in each group
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were incubated in the indicated media for 4 days or 6 days. At the end of the 4day or 6-day treatments, cells were lyzed and subjected for further analysis by
immunoblotting.
3.2.3 Protein Isolation and Immunoblotting
Cell dishes were kept on the ice and then culture medium was pumped
out through aspiration. Cells were washed once ice with 3 ml PBS. Then cells
were lysed in 400 microliters (μL) lysis buffer per dish. Whole cell lysates were
scraped into different centrifugation tubes (1.5 ml). Centrifugation tubes with
whole cell lysates were put on ice for more than 20 minutes. Then whole cell
lysates were centrifuged at 12,000 x g and 4°C for 15 minutes.
The protein concentration in the cell lysate supernatant was determined
with PIERCE BCA protein assay kit (Rockford, IL). This was achieved by first
mixing reagent A with reagent B (50:1) to make working reagent. Five μL of each
unknown sample was then pipetted into 495 uL dd H2O in seperate labeled
tubes. The standard protein stock (2 mg/mL) was diluted to 80, 40, 20, 10, 5 and
0 ug/uL for making standard curve according to the manufacture’s protocol. In 1
ml reaction, 500 μL of the working reagent was then added to each sample and
standard protein sample.
OD reading at 560 nm was measured using a 96 plate reader (560 nm). A
standard curve was prepared by plotting the average Blank-corrected 560 nm
OD readings vs. the concentrations in μg/mL. A formula derived from regression
was obtained and used to determined the total protein concentraion of each
sample.
To make the resolving gel, 5.9 mL ddH2O, 5 mL 30:0.8% w/v
acrylamide:bisacrylamide, 3.8 mL 1.5M Tris-Cl pH 8.8, 150 μL 10% SDS were
mixed together and 150 μL ammonium persulfate and 6 μL of TEMED were
added. To make the stacking gel, 4.1 mL ddH2O, 1 mL 30:0.8% w/v
acrylamide:bisacrylamide, 750 μL 1.0M Tris-Cl pH 6.8, 60 μL 10% SDS were
mixed together and 60 μL ammonium persulfate and 6 μL of TEMED were added
finally.
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After quantification, 40 μg total cell proteins were separated on 8% SDSPAGE gel. Then separated proteins were transferred from gel to Immobilon®PSQ PVDF membrane, which was blocked with 5% milk diluted in 1x TBST at
room temperature for one hour. The primary antibodies were diluted in TBST
containing 5% BSA or dry milk according to the manufactures’ instruction. The
membrane was incubated in the first antibody at 4 °C for overnight. The
membranes were washed three times with 1x TBST (5 minutes each time) later
after overnight incubation. Goat anti-rabbit IgG conjugated to horseradish
peroxidase (second antibody) was diluted in 5% milk or 5% BSA in 1x TBST
(1:1000). The membrane was incubated in the second antibody for one hour. The
membrane was washed for another three times with 1x TBST (5 minutes each
time). Next, ECL Western Blotting Substrate was used to cover the membrane
for visualization of the protein bands. Konica SRX 101A Film Processor was
used to develop the film. Quantification analysis was performed on Image J
software (NIH, Bethesda, Maryland, USA). The density of a protein band was
calculated by subtracting the background in an area of the same size near it.
Then, the ratio of the densities of the indicated protein to that of the control
protein (protein of interest/β-actin) was calculated for quantification.
3.2.4 Statistical Analysis
All experiments were repeated for three times. One-way ANOVA with LSD
post-hoc statistical analysis was conducted using SPSS version 22 statistical
software (IBM, Armonk, NY, U.S.A.). Data were presented as means ± S.E.M.
The difference was considered significant when the p-value was less than 0.05.

3.3 Results
3.3.1 RA treatment Inhibits the GLUT4 expression in L6 Cells on Day 4
L6 cells were used here to research the effects of RA doses and insulin on
the protein expression of GLUT4 in differentiating L6 cells. Figure 8 A shows a
representative blot of GLUT4 in L6 cells treated with RA doses or 10 nM insulin
for 4 days. Figure 8 B shows the summarized data of three independent studies.
As shown in Figure 8 B, GLUT4 expression level on Day 4 in L6
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Figure 8 Changes in GLUT4 expression in the medium of L6 cells treated with increasing
doses of RA and 10 nM insulin on Day 4. A: A representative blot of protein levels of GLUT4,
and β-actin in L6 cells treated with 2% HS (control), insulin (10 nM), RA (1 uM), and RA + insulin
for 4 days and 6 days. B: Quantification analysis of GLUT4. Cells were maintained in 60 mm
dishes and were subjected to differentiation with 2% HS alone (control), 2% HS + insulin (10 nM),
2% HS + RA (0.3-10 uM), or 2% HS + insulin(10nM) + RA (0.3-10 uM). The medium in each plate
was replaced every 2 days with its respective treatment condition. On day 4 of treatment, whole
cell lysate was collected as described in Materials & Methods. The ratio of the densities of GLUT4
to β-Actin was used to analyse data with control group set as 1. All p-values İ 0.05, a>b>c>d,
One-way ANOVA is used to analyse data.(means ± S.E.M (n=3))
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control cells (RA 0 μM, insulin 0 nM) is significantly higher than that in other
groups treated with RA at 0.3,1,3, or 10 uM RA or 10 nM insulin. This result
proved that RA treatment can inhibit the expression of GLUT4. GLUT4
expression of Day 4 in L6 cells of the control group is also significantly higher
than that in the insulin only treatment group (RA 0 μM, insulin 10 nM). This result
proved to us that insulin can inhibit the expression of GLUT4. GLUT4 expression
of L6 cells treated with 0.3 μM RA was significantly lower than that of L6 cells
treated with 0.3 μM RA and10 nM insulin. This result indicates that insulin and
RA may have synergistic effect on the expression of GLUT4 when the dose of
RA was 0.3 μM. Its expression in L6 cells treated with 0.3 μM RA was
significantly different from the insulin only group (RA 0 μM, insulin 10 nM). As a
result, 10 nM insulin has significant influence on the expression of GLUT4 on
Day 4. GLUT4 expression of L6 cells on Day 4 treated with 0.3 μM RA was
significantly higher than those treated with 1 μM RA and 10 nM insulin. GLUT4
expression of L6 cells treated with 1 μM RA was significantly different from L6
cells treated with 10 μM RA which also proves to us that different doses of RA
(1uM and 10uM) have different effects on GLUT4 expression of Day 4. On day 4,
the GLUT4 expression of L6 cells treated with 1 uM RA were significantly higher
than those treated with 10 μM RA and 10 nM insulin. This result proved to us that
insulin (10 nM) and RA (1 μM) synergized to inhibit the expression of GLUT4 in
L6 cells on Day 4. GLUT4 expression of L6 cells treated with 3 μM RA was
significantly different from L6 cells treated without RA and insulin (RA 0 μM,
insulin 10 nM).
In summary, the results shown in 8 B indicate that RA can dosedependently inhibit the expression of GLUT4 in the differentiating L6 cells after
the treatment for 4 days. Insulin can also inhibit the expression of GLUT4. Insulin
(10 nM) and RA (1 μM) have synergized to inhibit the expression of GLUT4.
3.3.2 RA treatment Inhibits the Expression of GLUT4 in L6 Cells on Day 6
Figure 9 A shows a representative blot of GLUT4 in L6 cells treated with
increasing concentrations of RA in the absence or presence of 10 nM insulin for
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Figure 9 Changes in GLUT4 expression in the medium of L6 cells treated with increasing
doses of RA and 10 nM insulin on Day 6. A: A representative blot of protein levels of GLUT4,
and β-actin in L6 cells treated with 2% HS (control), insulin (10 nM), RA (1 uM), and RA + insulin
for 6 days. B: Quantification analysis of GLUT4. Cells were maintained in 60 mm dishes and were
subjected to differentiation with 2% HS alone (control), 2% HS + insulin (10 nM), 2% HS + RA
(0.3-10 uM), or 2% HS + insulin(10nM) + RA (0.3-10 uM). The medium in each plate was
replaced every 2 days with its respective treatment condition. On day 6 of treatment, whole cell
lysate was collected as described in Materials & Methods. The ratio of the densities of GLUT4 to
β-Actin was calculated to do data analysis with control group set as 1. All p-values İ 0.05,
a>b>c>d, One-way ANOVA was used to analyse data( means ± S.E.M (n=3)).
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6 days. Figure 9 B shows the data from three independent studies. As shown in
Figure 9 A, GLUT4 expression level on Day 6 in L6 cells of the control group was
significantly higher than the other groups treated with RA (0.3 μM,1 μM,3 μM,10
μM) and/or insulin (10 nM). This result proved that RA can inhibit the expression
level of GLUT4. GLUT4 expression level in L6 cells of the control group on Day 6
is also significantly higher than the insulin treatment group (RA 0 μM, insulin 10
nM). This result proved to us that insulin can inhibit the expression of GLUT4.
In summary, based on the data shown in Figures 8 A&B and 9 A&B, both
RA and insulin inhibit the expression levels of GLUT4 in L6 cells after 4 and 6
days of treatment. The synergy between RA and insulin can be seen at Day 4
with 1 μM RA.
3.3.3 Insulin influence the Phosphorylation of Akt in L6 Cells
To determine whether the insulin treatment leads to changes of insulin
signal transduction in L6 cells, we measured the phosphorylated Akt (pAkt) at
serine 473. As shown in Figure 10 A&B, protein levels of pAkt in L6 cells
following one-hour treatment of 100 nM insulin were significantly higher than pAkt
expression in L6 cells following one-hour treatment of 10 nM insulin. Protein
levels of pAkt in L6 cells following one-hour treatment of 10 nM insulin doses
were significantly higher than pAkt expression in control group (insulin 0 nM).
This result indicates that insulin treatment for one hour caused phosphorylation
of Akt in L6 cells. Cells treated with 100 nM insulin had higher pAkt than 10 nM
insulin. At one hour after the treatment, pAkt protein levels in L6 cells of 0 nM,
0.1 nM and 1 nM insulin groups were not different. As described in Figure 10
C&D, protein levels of GLUT4 in L6 cells after one-hour treatment of insulin
doses were not significantly different from each other.
In summary, both 10 nM and 100 nM insulin exhibit its function in L6 cells
following one-hour treatment. However, GLUT4 expression in 10nM and 100 nM
insulin treatment groups were almost the same with the control group, indicating
that one-hour insulin treatment will not affect GLUT4 expression in L6 cells on
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Figure 10 pAkt and GLUT4 protein levels in L6 cells following one-hour treatment of
insulin doses. Cells were maintained in 60 mm dishes and were subjected to differentiation with
2% HS for 6 days. Following differentiation, L6 cells were treated with 2% HS (control), insulin (0
nM, 0.1 nM, 1nM, 10 nM, 100 nM) for 1 hour. Following treatment, whole cell lysate was collected
as described in Materials & Methods. The ratios of the densities of pAkt to total Akt and GLUT4 to
β-actin were calculated to do data analysis with control group set as 1. A&C: A representative blot
of protein levels of pAkt, GLUT4 and β-actin. B&D: Quantification analysis of pAkt and GLUT4.
All p-values İ 0.05; a>b>c. One-way ANOVA was used to analyse data(means f S.E.M (n=3)).
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Day 6 in the current experimental setting. Insulin does not have a significant
influence on the GLUT4 protein level.
3.3.4 Insulin and RA Inhibit the Expression of GLUT4 Protein Level
L6 cells were treated with 1 μRA, 10 nM insulin and their combination for 6
days again to test the GLUT4 expression. As shown in Figure 11 A&B, GLUT4
expression on Day 4 in L6 control cells was significantly higher than that in cells
treated with 1 μM RA or 10 nM insulin. This result proved that RA or insulin alone
can significantly inhibit the expression of GLUT4 protein level. GLUT4 expression
on Day 4 in L6 cells treated with 1 μM RA and 10 nM insulin was significantly
lower than the RA or insulin alone group, demonstrating a synergy between
them. In summary, according to the results shown in Figure 11 A&B, in the 4days , in the 4-day RA and insulin experiment, we found 1 μM RA and 10 nM
insulin can inhibit the expression of GLUT4. RA and insulin have a synergistic
effect to inhibit the expression of GLUT4 at the protein level in L6 cells treated
with RA and insulin for 4 days.
As shown in Figure 12 A&B, the GLUT4 protein level in L6 control cells
after differentiation for 6 days were significantly higher than L6 cells treated with
1 μM RA, 10 nM insulin, and RA + insulin. This result proved that RA and insulin
significantly alone inhibit the expression of GLUT4 protein level.
As described in Figure 12 A&B, the GLUT4 protein level in L6 cells treated
with 1 μM RA for 6 days was significantly higher than cells treated with 1 μM RA
and 10 nM insulin. GLUT4 protein level in L6 cells treated with 10 nM insulin for 6
days were not significantly different from L6 cells treated with 1 uM RA and 10
nM insulin.
In summary, according to the results shown in Figure 11 A&B, we found 1
uM RA and 10 nM insulin can inhibit the expression level of GLUT4 on Day 4. RA
and insulin do not have a synergy to inhibit the expression of GLUT4 protein level
on Day 6.
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Figure 11 Decrease of GLUT4 protein levels in L6 cells treated with insulin and RA for 4
days. A representative blot of protein levels of GLUT4 and β-actin in L6 cells treated with 2% HS
(control), insulin (10 nM), RA (1 uM), and RA + insulin for 4 days. Cells were maintained in 60
mm dishes and were subjected to differentiation with 2% HS (control), insulin (10 nM), RA (1 uM),
and RA + insulin. The medium was replaced every 2 days with its respective treatment condition.
On day 4 of treatment, whole cell lysate was collected as described in Materials & Methods. B:
Quantification analysis of GLUT4 and β-actin in L6 cells on Day 4. The ratio of the densities of
specified proteins to β-actin was calculated to do data analysis with control group set as 1. All pvalues İ 0.05; One-way ANOVA was used to analyse data.
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Figure 12 Decreases of GLUT4 protein levels in L6 cells treated with insulin and RA for 6
days. A representative blot of protein levels of GLUT4 and β-actin in L6 cells treated with 2% HS
(control), insulin (10 nM), RA (1 uM), and RA + insulin for 6 days. Cells were maintained in 60
mm dishes and were subjected to differentiation with 2% HS (control), insulin (10 nM), RA (1 uM),
and RA + insulin. The medium was replaced every 2 days with its respective treatment condition.
On day 6 of treatment, whole cell lysate was collected as described in Materials & Methods. B:
Quantification analysis of GLUT4 and β-actin in L6 cells on Day 6. The ratio of the densities of
specified proteins to β-actin was calculated to do data analysis with control group set as 1. All pvalues İ 0.05; One-way ANOVA statistical analysis was performed using SPSS software.
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3.4 Discussion
The aim of this part of the thesis was to understand how RA can influence
the glucose metabolism in skeletal muscle cells. In this study, GLUT4 expression
in L6 cells were tested. Insulin is an important hormone that regulates skeletal
glucose metabolism. Both the expression of GLUT4 and the translocation of
GLUT4 can be regulated by insulin. Insulin can stimulate the mobilization of the
GLUT4. It has been proved that acute insulin treatment via hind limb perfusion or
in viva injection can increase GLUT4 in plasma membrane fraction but decrease
GLUT4 in the intracellular membrane fraction.79 Those results suggest that
GLUT4 protein expression is a crucial factor in skeletal glucose metabolism.
In this study, insulin can inhibit the expression of the GLUT4 protein in L6
skeletal muscle cells on Day 4 and 6 as shown in Figure 8 and 9. These results
indicate that insulin treatment actually can decrease the GLUT4 protein
expression levels in the differentiated L6 skeletal muscle cell. The results shown
here suggest that insulin treatment for more than 4 days probably triggered a
feedback mechanism by which GLUT4 protein level begins to be reduced. This
finding may have physiological meanings as hyperinsulinemia is observed in
patients with insulin resistance. Whether the high plasma insulin level in those
patents initiates the drop of GLUT4 expression remains to be determined.
RA also dose-dependently inhibits the GLUT4 expression in L6 cells on
Day 4 and 6. This finding is important because there were only limited studies
about the effect of RA on differentiated skeletal muscle cells. The inhibitory
effects of RA on GLUT4 expression in differentiated L6 cells also indicate that
caution needs to be taken when obese or diabetes patients are given dietary
advice regarding VA supplement. Based on our study, supplying the system with
more RA seems not to help the control of glucose if the expression of the GLUT4
protein is inhibited. Excessive intake of VA may lead to more RA production
which may cause the decrease of the expression level of GLUT4 protein in obese
or diabetic patients. This may have negative effects on the regulation of skeletal
glucose homeostasis in those patients.
47

The effects of RA and insulin combination on GLUT4 protein level in L6
cells was also conducted in this study. GLUT4 protein level of L6 cells treated
with 10 nM insulin for 4 days were significantly higher than L6 cells treated with 1
μM RA and 10 nM insulin. This result indicates that 1 μM RA can further inhibit
the expression of GLUT4 in the present of 10 nM insulin. The synergistic effect of
RA and insulin further proved to us the negative influence of VA supplement if it
was recommended to patients with obese or diabetes. According to the results
shown in Figure 11, RA and insulin have a synergistic effect to inhibit the
expression of GLUT4 at protein level. Matt Goff who worked in the same lab as
me had found that the glucose usage of differentiated skeletal muscle cells
treated with RA and insulin for 4 days increase significantly.81 The decrease
protein level of GLUT4 cannot explain the increase of glucose usage of L6 cells.
However, GLUT4 is not the only type of glucose transporter found in skeletal
muscle, GLUT1 and GLUT3 were also expressed in skeletal muscle.73 Matt has
observed the reduction of GLUT1 in L6 cells treated the same way. On the other
hand, he has observed the induction of GLUT3 and GLUT6 expression levels
after RA or insulin treatment.81 The expression levels of GLUT1, GLUT3 and
GLUT6 were not tested in this study. Since the L6 cells treated with RA and
insulin have the increase of glucose usage, glucose probably gets into the cells
through other GLUTs. Whether the changes of other GLUTs in L6 cells contribute
to the elevated glucose usage remains to be investigated.

3.5. Conclusion
In this study, RA inhibited GLUT4 expression in L6 cells treated with 1 μM
RA and/or 10 nM insulin. Moreover, our data also show the synergism of RA and
insulin on GLUT4 protein expression. These results suggest that obese or
diabetes patient should be cautious when they are given dietary
recommendations such as VA supplements. This is because the GLUT4
expression is important for the uptake of glucose in skeletal muscle.
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CHAPTER FOUR
EFFECTS OF RA ON LIPID ACCUMULATION AND
GLUT4 EXPRESSION IN 3T3-L1 CARΔ1 ADIPOCYTES
4.1 Introduction
VA is one important type of fat-soluble micronutrient which is important for
the growth and development of animals.24RA is an active metabolite of retinol
which mediates the major functions of VA. One key role of RA is to regulate gene
expression. RA can bind to nuclear receptors in the cell to regulate gene
expression. RA can activate both RARs and RXRs in the nuclear receptor super
family. Additionally, COUPTF II and HNF4α are transcriptional factors that can
influence the expression of RA-regulated gene recently.25
Excess lipid accumulation can lead to obesity. Exploring of the regulation
of adipogenesis can help us overcome obesity and associated pathologies. The
main function of adipocytes is to balance energy in body.19 Moreover, adipocytes
can secrete important endocrine hormones such as leptin and adiponectin to
regulate metabolism in the whole body. Both leptin and adiponectin regulate
metabolism to control the body mass in healthy subjects.19
Studies on the mechanisms associated with adipogenesis have been
done in cultured cell models, such as 3T3-L1 ﬁbroblast cells. Insulin,
glucocorticoid receptor agonist, and phosphodiesterase inhibitor can initiate the
differentiation of 3T3-L1 ﬁbroblast cells. Phosphodiesterase inhibitor can elevate
adenosine 3’,5’-cyclic monophosphate (cAMP) levels. Differentiation of 3T3-L1
cells can be triggered because of the treatment with this mixture. 73 In contrast,
RA can negatively regulate adipocyte differentiation. 82 It has been shown that RA
inhibits adipocyte differentiation of 3T3-L1 preadipocytes.82 GLUT4 is an
insulin-stimulated glucose transporter. Insulin stimulation leads to the movement
of GLUT4 from an intracellular location to the cell membrane, a process that
leads to elevation of glucose entry into adipocytes. On the other hand, GLUT4
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protein expression increases with the differentiation process.83 The mechanism
of this induction of GLUT4 expression in association with differentiation is still
unclear.
The aim of this part of the thesis is to understand how RA can influence
the lipid and glucose homeostasis in adipocytes. We took advantage of 3T3-L1
CARΔ1 cells, a cell line allowing for transfection of recombinant adenoviruses. 75
The levels of RXRα and COUP-TFII were overexpressed in 3T3-L1 CARΔ1 cells
via transfection of ad-RXRα and ad-COUPTFII. We found that RA treatment and
overexpression of RXRα in differentiated 3T3-L1 CARΔ1 cells resulted in the
reduction of lipid accumulation. We also observed that RA treatment reduced the
GLUT4 expression in differentiating 3T3-L1 CARΔ1 cells, a phenomenon that
can be attenuated in the presence of RXRα overexpression.

4.2 Materials and Methods
4.2.1 Reagents
3T3-L1 CARΔ1 cells were provided by Dr. D. Orlicky (University of
Colorado, Denver, CO).75 For 3T3-L1 CARΔ1 adipocytes culture and
differentiation, 3T3-L1 differentiation medium (DMEM+10%FBS+1% 3-isobutyl-1methylxanthine +0.1% Insulin+0.1% dexamethasone+ P/S) and 3T3-L1
maintenance medium (DMEM + 10%CS + P/S) were purchased from Zenbio
Company (Research Triangle Park, NC, U.S.A.).
Insulin and all-trans RA and were purchased from Sigma Aldrich, Corp (St.
Louis, MO, U.S.A.). BCA protein assay kit was purchased from Pierce
Biotechnology, Inc (Rockford, IL, U.S.A.) to test the protein concentration.
Immobilon®-PSQ PVDF membrane was purchased from EMD Millipore Corp
(Billerica, MA, U.S.A.). Food Club Non-fat dry milk were purchased from a
grocery store (St. Abingdon, VA, U.S.A) to block the membrane and to make the
first antibodies (GLUT4, β-Actin, RXRα, COUPTFII). Protease-free bovine serum
albumin (BSA) was purchased from Fisher BioReagents™ to prepare primary
antibodies from Cell Signaling Technology. For immunoblotting, GLUT4 antibody
(C-terminus) was purchased from EMD Millipore Corp (Billerica, MA, U.S.A.). β50

Actin (#4970), total Akt (#9272), phospho-Akt (Ser473) antibody, RXRα,
COUPTFII, and horseradish peroxidase conjugated-goat anti-rabbit IgG (#7074)
were purchased from Cell Signaling Technology (Danvers, MA, U.S.A.). ECL
Western Blotting Substrate were purchased from Pierce Biotechnology, Inc
(Rockford, IL, U.S.A.).
4.2.2 Preparation of Recombinant Adenoviruses
Recombinant adenoviruses, Ad-β-gal, Ad-RXRα, and Ad-COUPTFII have
been used and published previously.84 The methods of recombinant adenovirus
generation have been demonstrated before.84 When HEK 293 cells grown to
80% confluence in 150 mm tissue culture plates, confirmed original crude lysate
was then used to infect HEK 293 cells. The ratio of the medium to crude lysate is
10 to 1 (v/v). After around 48-hour post infection, culture media and cells were
collected, which was designated as the crude lysate. New crude lysates of adRXRα and ad-COUPTFII were stored at -80°C until being used.
4.2.3 3T3-L1 CARΔ1 Adipocyte Cell Culture and Differentiation
3T3-L1 cells with the expression of CAR Δ1 is termed as 3T3-L1 CAR
Δ1 cells. The efficiency of transduction of recombinant adenovirus in 3T3-L1
CAR Δ1 cells increased approximately 100-fold comparing with than in parental
3T3-L1 cells. 3T3-L1 CARΔ1 adipocytes were maintained in 60 mm dishes in the
incubator (37°C, 5% CO2, and 95% air) with 3T3-L1 maintenance medium
(DMEM+10%CS+P/S). 3T3-L1 CARΔ1 adipocytes were seeded in 12-well
plates with inoculum 3×105 cells per well. When cells reached near 100%
confluence in the 12-well plates (Day 0), the medium was changed to 3T3-L1
differentiation medium supplemented with RA and crude lysate of adenovirus
(ad-β-gal, ad-RXRα or ad-COUPTFII). Cells were separated into different groups
as follow.
On Day 3, the media of cells with different treatments were changed to
fresh differentiation media once. On Day 5, differentiation medium was changed
to maintenance medium with the same doses of RA. On Day 7, cells in the 12well plates were fixed to for Oil Red O Staining. Then cells were observed under
51

Table 1 Different treatment groups of 3T3-L1 CARΔ1 adipocytes tranfected with or without
adenovirus.
A.

B.

C.

D.

Non viral

Non-DM+0

DM+0 μM

DM+0.3

DM+1 μM

DM+3 μM

DM+3 μM

Control

μM RA

RA

μM RA

RA

RA

RA

Ad-β-gal

Non-DM+0

DM+0 μM

DM+0.3

DM+1 μM

DM+3 μM

DM+10 μM

μM RA+ Ad-

RA+ Ad-β-

μM RA+

RA+ Ad-β-

RA+ Ad-β-

RA+ Ad-β-

β-gal

gal

Ad-β-gal

gal

gal

gal

Non-DM+0

DM+0 μM

DM+0.3

DM+1 μM

DM+3 μM

DM+10 μM

μM RA+ Ad-

RA+ Ad-

μM RA+

RA+ Ad-

RA+ Ad-

RA+ Ad-

RXRα

RXRα

Ad-RXRα

RXRα

RXRα

RXRα

Ad-

Non-DM+0

DM+0 μM

DM+0.3

DM+1 μM

DM+3 μM

DM+10 μM

COUPTFII

μM RA+ Ad-

RA+ Ad-

μM RA+

RA+ Ad-

RA+ Ad-

RA+ Ad-

COUPTFII

COUPTFII

Ad-

COUPTFII

COUPTFII

COUPTFII

Ad-RXRα

COUPTFII

Note: cells in groups A to D in non-differentiated (1) or differentiated (2 to 5) conditions were
treated without (1 and 2) or increasing concentrations (3 to 6) of RA for 7 days.
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the optical microscope (Phase Contrast Objectives: LWD PH, 10 × 0.25). Then
pictures were taken under a microscope (LWD PH, 20 × 0.4) via Micro Software
(Pittsburgh, Pennsylvania USA). Oil red O retained in the cells was dissolved in
isopropanol. Optical Density at 500 nm of these lysates was read for
quantification.
For the long-term RA dosage curve experiment, when cells reached near
100% confluence (Day 0) in the 60 mm dishes, 3T3-L1 maintenance medium
was changed to 3T3-L1 differentiation medium with increasing concentrations of
RA in the presence of Ad-β-gal, Ad-RXRα or Ad-COUPTFII. Cells were
separated into different groups as described in Table 4.1. On Day 3, the media of
cells with different treatments were changed to differentiation media containing
the indicated reagents once. On Day 5, differentiation medium was changed to
maintenance medium with the same doses of RA. On Day 7, cells were collected
for analysis of protein levels using immunoblotting.
4.2.4 Oil Red O Staining
3T3-L1 CARΔ1 adipocyte were seeded in 12-well plates. After the cell
differentiation process, old medium was removed, and 1 ml 10% formalin was
added to fix cells in each well. Cells were incubated in 10% formalin for
overnight. On the next day, 10% formalin in each well was removed, and 1 ml
distilled deionized water (dd H2O) was added to wash the cells for 3 times. 0.35 g
Oil-Red-O was dissolved in 100 ml 100% isopropanol to mix well for at least 20
minutes to make Oil-Red-O stock solution. Then Oil-Red-O stock was filtered
with 0.2 μm syringe filter. Three parts of the Oil-Red-O stock solution to two parts
of dd H2O were mixed well together to make Oil-Red-O working solution. Then
Oil-Red-O working solution was filtered with 0.2 μm syringe filter. dd H2O in the
12-well plates was removed, and Oil-Red-O working solution was added to each
well of the plate. The fixed cells were incubated in Oil-Red-O (1 ml per well)
working solution for 20 minutes. Cells were washed 3 times again with dd H2O
and then, maintained in dd H2O to cover cells. Then, cells were observed under
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the microscope immediately after doing Oil-Red-O Staining and pictures of cells
were taken.
Water in the 12-well plate with differentiated cells was removed, and cells
were let dry. Then, 400 μL 100% isopropanol was added to each plate and
incubated for 20 minutes to elute Oil-Red-O at room temperature. To make sure
that all Oil-Red-O in the solution was eluted, the isopropanol solution was
pipetted several times to mix. The solubilized Oil-Red-O solution was transferred
to 96-well plate to read OD 500 nm using a Glomax® Multi+Detection System.
4.2.5 Protein Isolation and Immunoblotting
Cell dishes were kept on ice and then culture medium pumped out through
aspiration. Cells were washed once with 3ml ice cod PBS. Then cells are lysed in
400 μl lysis buffer per dish. Whole cell lysates were scraped into different
centrifugation tubes (1.5 ml). Centrifugation tubes with whole cell lysates were
put on ice for more than 20 minutes. Then whole cell lysates were centrifuged at
12,000 x g and 4°C for 15 minutes. Supernatants were collected into new 1.5 ml
centrifugation tubes and stored in the freezer (-80°C).
The protein concentration in the cell lysate supernatant was determined
with PIERCE BCA protein assay kit (Rockford, IL). This was achieved by first
mixing reagent A with reagent B (50:1) to make working reagent. Five μL of each
unknown sample was then pipetted into 495 uL dd H2O in seperate labeled
tubes. The standard protein stock (2 mg/mL) was diluted to 80, 40, 20, 10, 5 and
0 ug/uL for making standard curve according to the manufacture’s protocol. In 1
ml reaction, 500 μL of the working reagent was then added to each sample and
standard protein sample.
OD reading at 560 nm was measured using a 96 plate reader (560 nm). A
standard curve was prepared by plotting the average Blank-corrected 560 nm
OD readings vs. the concentrations in μg/mL. A formula derived from regression
was obtained and used to determined the total protein concentraion of each
sample.
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To make the resolving gel, 5.9 mL ddH2O, 5 mL 30:0.8% w/v
acrylamide:bisacrylamide, 3.8 mL 1.5M Tris-Cl pH 8.8, 150 μL 10% SDS were
mixed together and 150 μL ammonium persulfate and 6 μL of TEMED were
added. To make the stacking gel, 4.1 mL ddH2O, 1 mL 30:0.8% w/v
acrylamide:bisacrylamide, 750 μL 1.0M Tris-Cl pH 6.8, 60 μL 10% SDS were
mixed together and 60 μL ammonium persulfate and 6 μL of TEMED were added
finally.
After quantification, 40 μg total cell proteins were separated on 8% SDSPAGE gel. Then, separated proteins were transferred from gel to Immobilon®PSQ PVDF membrane, which was blocked by 5% milk diluted in 1x TBST at
room temperature for one hour. The primary antibodies were diluted in 1x TBST
containing 5% BSA. Then, the membrane was incubated in the first antibody at 4
°C for overnight. Then, the membrane was washed three times with 1x TBST (5
minutes each time). Horseradish peroxidase-conjugated goat anti-rabbit IgG
(second antibody) was diluted in 1x TBST containing 5% milk (1:1000). Then, the
membrane was incubated with the second antibody for one hour. The
membranes were washed for another three times with 1x TBST (5 minutes each
time). Next, ECL Western Blotting Substrate was used to cover the membrane,
which was exposed to X-ray film. Konica SRX 101A Film Processor was used to
develop the film. Quantification analysis was performed on Image J software
(NIH, Bethesda, Maryland, USA). The density of a protein band was calculated
by subtracting the background in an area of the same size near protein band.
Then, the ratio of the density of the indicated protein to that of the control protein
(protein of interest/β-actin) was calculated for quantification.
4 .2.6 Statistical Analysis
All experiments were repeated three times. One-way ANOVA with LSD
post-hoc statistical analysis was conducted using SPSS version 22 statistical
software (IBM, Armonk, NY, U.S.A.). Data were presented as means ± S.E.M. pvalue less than 0.05 was considered statistically significant.
55

4.3 Results
4.3.1 RA Inhibits Lipid Accumulation in 3T3-L1 CARΔ1 Cells
To study the RA effects on lipid accumulation, 3T3-L1 CARΔ1 cells were
differentiated in RA doses without or with Ad-β-gal transfection. In Figure 13 A,
lipid accumulation decreased with the increase of RA concentration. Figures 13
B, C&D show the quantification of the lipid accumulation data.
As shown in Figure 13 B, in the RA doses experiment, the control 3T3-L1 CARΔ1
adipocytes treated with differentiated medium had significantly higher lipid
accumulation than the 3T3-L1 CARΔ1 cells treated with maintenance medium.
This result indicated that 3T3-L1 CARΔ1 adipocytes were well differentiated in
differentiation medium. The amounts of lipid accumulation in those differentiating
3T3-L1 CARΔ1 cells treated with RA at 0.3, 1,3, and 10 μM were significantly
lower than that in differentiating 3T3-L1 CARΔ1 cells treated without RA. This
result proved to us that RA can significantly inhibit lipid accumulation in 3T3-L1
CARΔ1 cells during the differentiation process. There were no significant
differences of lipid accumulation between 3T3-L1 cells treated with RA at 0.3 μM
and 1 μM. The lipid accumulation in 3T3-L1 CARΔ1 cells treated with RA at 0.3
μM or 1 μM was significantly higher than that in those treated with RA at 3 μM.
This result indicates that RA at 3 μM can further inhibit the lipid accumulation in
3T3-L1 CARΔ1 cells compared with those treated with RA at 0.3 μM or 1 μM. As
a result, RA at 3 μM reached the highest inhibitory effect on lipid accumulation in
3T3-L1 CARΔ1 cells. The lipid accumulation in 3T3-L1 CARΔ1 cells treated with
RA at 0.3, 1, 3 or 10 μM RA was significantly higher than in those cells cultured
in non-differentiation medium. Although RA can inhibit the lipid accumulation in
3T3-L1 CARΔ1 cells, certain amount of lipid can still accumulate in 3T3-L1 cells
at a significant level.
As described in Figure 13 B, lipid accumulation in 3T3-L1 CARΔ1 cells
treated with differentiated medium was significantly higher than those treated
with maintenance medium. This result indicates that the 3T3-L1 CARΔ1 cells
transfected with ad-β-gal differentiated well. The amounts of lipid accumulation in
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Figure 13: RA Inhibits the Lipid Accumulation in 3T3-L1 CARΔ1 adipocyte cell treated with
or without ad-β-gal. A: lipid accumulation in differentiating 3T3-L1 cells treated with RA doses
with or without ad-β-gal. B, C&D: Quantification of lipid accumulation in 3T3-L1 CARΔ1 adipocyte
cell. The cells were cultured in triplicates for 120 h (5 days) in 3T3-L1 differentiation medium
containing different doses of RA. Ad-β-gal was added on Day 0 of differentiation. 3T3-L1
differentiation medium was changed to 3T3-L1 maintenance medium containing different
concentration of RA for 48 hours (2 days).
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3T3-L1 cells treated with RA at 0.3,1,3 and10 μM with differentiation medium
were significantly lower than that in 3T3-L1 CARΔ1 cells treated without RA in
differentiation medium. This result proved to us that RA can significantly inhibit
lipid accumulation in 3T3-L1 CARΔ1 cells infected with ad-β-gal during
differentiation process. There was no significant difference among differentiating
3T3-L1 cells treated with different doses of RA. The lipid accumulation in 3T3-L1
CARΔ1 cells treated with RA at 3 μM or 10 μM was not significantly different from
that treated with the non-differentiation medium. There was almost no lipid
accumulation in 3T3-L1 CARΔ1 cells treated with RA at 3 μM or 10 μM, which
indicates that RA at 3 μM or 10 μM can effectively inhibit the lipid accumulation in
3T3-L1 CARΔ1 cells transfected with Ad-β-gal. As a result, the inhibition of RA
on lipid accumulation in 3T3-L1 CARΔ1 cells is more obvious in cells transfected
with ad- β-gal. The transfection of ad-β-gal does not affect the inhibitory effect of
RA on the lipid accumulation in differentiating 3T3-L1 CARΔ1 cells.
When comparing the differentiating 3T3-L1 CARΔ1 cells treated with RA
doses in the absence of recombinant adenovirus transfection with that
transfected with ad-β-gal and treated with RA, there was no significant difference
of lipid accumulation in cells treated with RA at 0.3, 1, 3 or 10 μM. The lipid
accumulation in differentiating 3T3-L1 cells transfected with ad-β-gal was
significantly higher than that without viral transfection in RA 0 μM treatment
group. It suggests that transfection of recombinant adenovirus or overexpress of
β-gal may cause more lipid accumulation in the differentiation process. This
result demonstrated the importance to use ad-β-gal as a control group to study
the overexpression of other proteins.
In summary, RA can inhibit the lipid accumulation in differentiating 3T3-L1
cells in the absence or present of ad-β-galinfection. In the groups of
differentiating 3T3-L1 cells treated without ad-β-gal transfection, RA at 3 μM
presented the highest inhibitory effect. In the groups of differentiating 3T3-L1
CARΔ1 cells transfected with ad-β-gal, RA at 0.3,1, 3 and 10 μM presented
similar inhibitory effects on lipid accumulation. Either recombinant adenovirus or
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overexpress of β-gal may influence the function of RA to inhibit lipid accumulation
in differentiating 3T3-L1 cells. Therefore, 3T3-L1 cells infected with ad-β-gal can
serve as the controls for 3T3-L1 infected with ad-RXRα or COUPTFII.
4.3.2 RA Inhibits Lipid Accumulation in 3T3-L1 CARΔ1 Cells Transfected
with Ad-RXRα
The influence of RXRα overexpression on the lipid accumulation in 3T3-L1
CARΔ1 cells treated with increasing concentrations of RA were assessed by OilRed-O staining as shown in Fig. 13 A. Quantification of lipid accumulation in cells
transfected with ad-β-gal or ad-RXRα and treated with RA after differentiation
was done by the measurement of OD 500 nm. (Fig. 13 C).
Here, we conducted RA dosage experiment in 3T3-L1 CARΔ1 adipocytes
transfected with ad-β-gal or ad-RXRα. Figure 13 A also presents microscopic
pictures of the lipid accumulation in 3T3 cells treated with ad-β-gal or ad-RXRα.
As shown in Figure 13 C, lipid accumulation in ad-RXRα-transfected 3T3-L1
CARΔ1 adipocytes treated with differentiated medium without RA was
significantly higher than those with only maintenance medium. This result
indicated that the 3T3-L1 CARΔ1 cells were well differentiated when transfected
with ad-RXRα. The lipid accumulation in those differentiating 3T3-L1 CARΔ1
cells treated with RA at 0.3,1,3, or 10 μM was significantly lower than
differentiating 3T3-L1 CARΔ1 cells treated without RA. This result proved to us
that RA can significantly inhibit lipid accumulation in 3T3-L1 CARΔ1 cells
transfected with ad-RXRα during the differentiation process.
The lipid accumulation of the ad-RXRα-transfected 3T3-L1 CARΔ1 cells
treated without RA was significantly lower than those ad-β-gal-transfected cells
treated without RA. This result indicates that the overexpression of RXRα may
inhibit the lipid accumulation in differentiating 3T3-L1 CARΔ1 cells with no RA.
The lipid accumulation in ad-RXRα-transfected 3T3-L1 CARΔ1 cells treated with
RA at 0.3 μM had significantly lower lipid accumulation than the ad-β-galtransfected cells treated with 0.3 μM RA. The overexpression of RXRα may help
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to mediate the inhibitory influence of RA on lipid accumulation in differentiating
3T3-L1 CARΔ1 cells.
In summary, RA can significantly inhibit lipid accumulation in 3T3-L1
CARΔ1 cells transfected with ad-RXRα during the differentiation process.
Overexpression of RXRα may inhibit the lipid accumulation in differentiating 3T3L1 CARΔ1 cells in the absence or presence of RA.
4.3.3 RA Inhibits Lipid Accumulation in 3T3-L1 CARΔ1 Cells Transfected
with Ad-COUPTFII
The changes of lipid accumulation in 3T3-L1 CARΔ1 cells transfected with
ad-β-gal or ad-COUPTFII and treated with increasing concentrations of RA were
assessed by Oil-red-O staining as shown in Fig. 13 A. Quantification of lipid
accumulation changes in ad-β-gal-transfected or ad-CPOUTFII-transfected cells
were detected by measurement of OD 500 nm, as shown in Fig. 13 D.
Figure 13 A presents microscopic pictures of the lipid accumulation in cells
transfected with ad-β-gal or ad-COUPTFII. As described in Figure 13 D, the adCOUPTFII-transfected 3T3-L1 CARΔ1 cells treated with differentiation medium
without RA had significantly higher lipid accumulation than those treated with
only maintenance medium in the absence of RA. This result indicates that the
3T3-L1 CARΔ1 cells were well differentiated with ad-COUPTFII. There was no
significant difference between 3T3-L1 cells treated with RA at 0 μM and 0.3 μM
in the ad-COUPTFII-transfected 3T3-L1 CARΔ1 cells with differentiation medium.
There was no significant difference in 3T3-L1 cells treated with RA at 1 μM, 3 μM
or 10 μM. The lipid accumulation levels of ad-COUPTFII-transfected 3T3-L1
CARΔ1 cells treated with RA at 0 μM and 0.3 μM were significantly higher than
those treated with RA at 1 μM, 3 μM or 10 μM. As a result, RA can still inhibit the
lipid accumulation in differentiating 3T3-L1 CARΔ1 cells with the overexpression
of COUPTFII.
The lipid accumulation of ad-COUP-TFII-transfected cells was significantly
lower than ad-β-gal-transfected cells treated with differentiation medium in the
absence of RA. This result indicates that the overexpression of COUPTFII may
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inhibit the lipid accumulation in differentiating 3T3-L1 CARΔ1 cells. The lipid
accumulation levels of ad-β-gal-transfected and ad-COUP-TFII-transfected cells
treated with increasing concentrations of RA were not significantly different from
each other.
4.3.4 Differentiation process Increases GLUT4 Protein Level in 3T3-L1
CARΔ1 Adipocytes
To test the influence of RA treatment on GLUT4 expression and the
potentials of using recombinant adenovirus to alter the expression levels of
transcription factors, 3T3-L1 CARΔ1 adipocytes in differentiation process were
treated with RA doses and ad-β-gal. Fig 14 shows the expression levels of
GLUT4 and β-actin protein levels. The cells were cultured for 120 h (5 days) in
3T3-L1 differentiation medium containing 0, 0.3 ,1 ,3, or 10 μM RA. Ad-β-gal was
added at Day 0 of differentiation. 3T3-L1 differentiation medium was changed to
3T3-L1 maintenance medium containing 0, 0.3 ,1,3, or 10 μM RA after 48 hours
(2 days). All cultured cells on Day 7 were lyzed for western blot analysis of
protein expression.
As shown in Figure 14 on the left panel, in the non-differentiating group
without ad-β-gal transfection, there was almost no GLUT4 protein detected.
GLUT4 protein levels in differentiating 3T3-L1 CARΔ1 cells were obviously
higher than that in non-differentiating 3T3-L1 CARΔ1cells in the absence of ad-βgal transfection. This result proved that the differentiation process increases
GLUT4 protein level in 3T3-L1 CARΔ1 cells. We can observe a slightly decrease
trend of GLUT4 expression in the differentiating 3T3-L1 CARΔ1 cells treated with
RA at 0, 0.3, 1, 3 or 10 μM.
As shown in Fig 14 on the right panel, the Ad-β-gal-transfected 3T3-L1
CARΔ1 cells had almost no expression of GLUT4, which is similar to the cells
without any recombinant adenovirus transfection. The GLUT4 expression level in
ad-β-gal-transfected 3T3-L1 CARΔ1 cells was also slightly reduced with the
increase of RA concentration. We conclude that RA can inhibit the GLUT4
protein expression in differentiating 3T3-L1 CARΔ1 cells. Adenovirus-mediated
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Figure 14 Changes in GLUT4 expression in 3T3-L1 CARΔ1 Adipocyte Cell transfected with
or without Ad-β-gal. The cells were cultured in triplicates for 120 hours (5 days) in 3T3-L1
differentiation medium containing different doses of RA. Ad-β-gal was added on Day 0 of
differentiation. 3T3-L1 differentiation medium was changed to 3T3-L1 maintenance medium
containing different doses of RA for 48 hours (2 days). Whole cell lysate was collected on Day 7
as described in Materials & Methods. Blots were visually detected using ECL Western Blotting
Substrate. The ratio of the densities of GLUT4 to β-Actin was calculated to do data analysis with
control group set as 1.
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transfection has no significant influence on the GLUT4 protein levels in 3T3-L1
CARΔ1cells.
4.3.5 Overexpression of RXRα was achieved by ad-RXRα in Differentiating
3T3-L1 CARΔ1 Adipocytes
To explore the transcription factors that may mediate the RA-suppressed
GLUT4 protein expression in differentiating 3T3-L1 CARΔ1 cells, we compared
the RXRα and β-actin expression levels in 3T3-L1 cells transfected with ad-β-gal
or ad-RXRα as shown in Fig.4.3. The cells were cultured in triplicates for 120
hours (5 days) in 3T3-L1 differentiation medium containing 0, 0.3,1,3, or 10 μM
RA. Ad-β-gal and ad-RXRα were added at Day 0 of differentiation. 3T3-L1
differentiation medium was changed to 3T3-L1 maintenance medium containing
0, 0.3,1,3, or 10 μM RA after 48 hours (2 days). All cultured cells on Day 7 were
lyzed to do immunoblotting.
In Fig 4.3, RXRα protein level in ad-β-gal transfected 3T3-L1 CARΔ1 cells
treated with differentiation medium without RA was slightly higher than nondifferentiating 3T3-L1 cells in the absence of RA. There was almost no RXRα
detected in the Ad-β-gal-transfected 3T3-L1 CARΔ1 cells treated with RA at 0.3,
1, 3 or 10 μM in differentiation medium. As shown in Fig 4.3, RXRα protein was
detected in all groups of 3T3-L1 CARΔ1 cells in the presence of ad-RXRα
transfection. RA-suppressed RXRα expression is absent when RXRα is
overexpressed by ad-RXRα.
In the RA at 0.3, 1, 3 and 10 μM groups, RXRα protein level in ad-RXRαtransfected 3T3-L1 cells with differentiation medium were obviously higher than
ad-β-gal transfected 3T3-L1 cells in respective treatment groups. In the RA at 0
μM differentiation groups, RXRα protein level in ad-RXRα-transfected 3T3L1CARΔ1 cells with differentiation medium was higher than ad-β-gal transfected
3T3-L1 cells with differentiation medium. In the RA at 0 μM non-differentiation
groups, RXRα protein level in ad-RXRα-transfected 3T3-L1CARΔ1 cells with
differentiation medium was obviously higher than ad-β-gal transfected 3T3-L1
cells with differentiation medium.
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Figure 15 RXRα protein levels in 3T3-L1 CARΔ1 adipocytes. The cells were cultured in
triplicates for 5 days in 3T3-L1 differentiation medium containing 0, 0.3 ,1 ,3, or 10 μM RA. Ad-βgal or ad- RXRα was added at Day 0 of differentiation. 3T3-L1 differentiation medium was
changed to 3T3-L1 maintenance medium containing RA after treatment for 2 days. Whole cell
lysate was collected on Day7 as described in Materials & Methods. Blots were visually detected
using ECL Western Blotting Substrate. The ratio of the density of RXRα to that of β-Actin was
calculated to do analyze data with control group set as 1.
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Those results proved to us that recombinant adenovirus mediated the
overexpression of targeted proteins 3T3-L1 CARΔ1 cells in both nondifferentiated and differentiated conditions. This established the foundation for us
to use 3T3-L1 CARΔ1 for studies of protein functions through recombinant
adenovirus-mediated overexpression.
4.3.6 RA-mediated Reduction of GLUT4 Protein Level was Attenuated by
Recombinant Adenovirus-mediated RXRα Overexpression in Differentiating
3T3-L1 CARΔ1 Adipocytes
Fig 16 shows that GLUT4 protein levels in ad-β-gal-transfected or adRXRα-transfected 3T3-L1 CARΔ1cells treated with non-differentiation medium or
differentiation medium containing increasing concentrations of RA. The cells and
treatment were the same as Fig 15.
The GLUT4 protein levels in ad-β-gal-transfected 3T3-L1 CARΔ1 cells
treated with differentiation medium containing RA at 0, 0.3,1,3 or 10 μM were
significantly higher than that treated with non-differentiation medium. There were
almost no GLUT4 detected in the non-differentiating cells treated without RA.
This result further proved that the differentiation process led to the induction of
GLUT4 protein expression in 3T3-L1 CARΔ1 cells. GLUT4 protein level in
differentiating cells treated with RA at 0, 0.3 or 1 μM were almost same with each
other. GLUT4 protein level in differentiating cells treated with RA at 3 or 10 μM
were significantly lower than differentiating cells treated without or with 0.3 μM
RA. We conclude that RA inhibits the GLUT4 protein level in ad-β-gal-transfected
3T3-L1 CARΔ1 cells during the process of differentiation.
Similar to the results in the groups of 3T3-L1 cells with β-gal transfection,
GLUT4 protein levels in the non-differentiating cells without RA treatment was
significantly lower than the differentiating 3T3-L1 cells with RXRα
overexpression. GLUT4 protein levels in differentiating cells treated with RA at 0,
0.3, 1, 3 and 10 μM were almost same with each other in the 3T3-L1 cells with
RXRα overexpression. Moreover, when compared GLUT4 levels in differentiating
3T3-L1 CARΔ1 cells with β-gal transfection with that with RXRα transfection in
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Figure 16 GLUT4 protein levels in 3T3-L1 CARΔ1 adipocytes transfected with Ad-β-gal or
Ad-RXRα. The cells were cultured in triplicates for five days in 3T3-L1 differentiation medium
containing 0, 0.3,1,3, or 10 μM RA. Ad-β-gal or ad-RXRα was added at Day 0 of differentiation.
Differentiation medium was changed to maintenance medium after two days. Whole cell lysate
was collected on Day7 as described in Materials & Methods. Blots were visually detected using
ECL Western Blotting Substrate. The ratio of the density of GLUT4 to that of β-Actin was
calculated to do data analyze with control group set as 1. A: A representative blot of protein levels
of RXRα and β-actin in 3T3-L1 CARΔ1 adipocytes. B: Quantification analysis of RXRα. All pvalues İ 0.05, a>b>c>d>e, One-way ANOVA was used to analyze data ( means ± S.E.M (n=3))
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in the RA at 3 μM or 10 μM treatment group, we found that the protein level of
GLUT4 in ad-RXRα transfected 3T3-L1 cells were significantly higher than that in
ad-β-gal-transfected 3T3-L1 cells treated with RA at the respective dosages. We
already proved that RXRα was overexpressed successfully by ad-RXRα in both
non-differentiated and differentiated 3T3-L1 cells as shown in Figure 15. We
conclude that RA inhibits the expression of GLUT 4 in differentiated 3T3-L1
CARΔ1 cells with β-gal transfection. Interestingly, when RXRα was
overexpressed in 3T3-L1 CARΔ1 cells, it attenuated the inhibitory effects of RA
on GLUT4 expression. GLUT4 protein level was increased as a result. This
finding is novel and very important to understand the glucose metabolism in 3T3L1 CARΔ1 cells.
4.3.7 COUPTFII was Overexpressed Successfully by recombinant
adenovirus in 3T3-L1 CARΔ1 Adipocytes
We have shown that COUP-TFII also affected the RA signaling.84
Therefore, we also overexpressed COUP-TFII to study its effect on GLUT4
expression in 3T3-L1 CARΔ1 cells. Fig 17 shows that GLUT4 protein levels in
ad-β-gal-transfected or ad-RXRα-transfected 3T3-L1 CARΔ1 cells treated with
non-differentiation medium or differentiation medium containing increasing
concentrations of RA. Cells were treated the same as that in Fig. 16.
COUPTFII protein levels in ad-β-gal-transfected 3T3-L1 cells treated with
differentiation medium presented a trend of elevation with the increasing of RA
doses. RA may help to increase the induction of COUPTFII in differentiating 3T3L1 CARΔ1 cells. COUPTFII protein levels in differentiating ad-β-gal-transfected
3T3-L1 CARΔ1 cells treated with RA at 0, 0.3, 1, 3, and 10 μM were all higher
than the non-differentiating ad-β-gal-transfected 3T3-L1 CARΔ1 cells without RA.
This result proved to us that differentiation process may increase the protein level
of COUPTFII.
The COUPTFII protein levels in ad-COUP-TFII-transfected 3T3-L1 CARΔ1
cells treated with differentiation medium were obviously higher than that treated
with non-differentiation medium as shown Fig. 17 right panel. The cells treated
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Figure 17 COUPTFII protein levels in 3T3-L1 CARΔ1 adipocytes. The cells were cultured in
triplicates for five days in 3T3-L1 differentiation medium(DM) containing 0, 0.3,1,3, or 10 μM RA.
Ad-β-gal or ad- COUPTFII was added at Day 0 of differentiation. DM was changed to
maintenance medium for two days. Whole cell lysate was collected on Day7 as described in
Materials & Methods. Blots were visually detected using ECL Western Blotting Substrate. The
ratio of the density of COUPTFII to that of β-Actin was calculated to do data analysis with control
group set as 1.
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with RA at 0, 0.3, 1, 3, and 10 μM had similar amount of COUP-TFII expression
in differentiating ad-COUP-TFII-transfected 3T3-L1 cells. This result further
proved to us that differentiation medium which contains insulin may induce the
expression of COUPTFII.
When compared the expression levels of COUP-TFII in ad-β-gal transfected 3T3-L1 CARΔ1cells with that in the ad-COUP-TFII-transfected one,
we found that the protein level of COUPTFII in non-differentiated 3T3-L1 cells
with COUPTFII overexpression was a little lower than that in differentiating adCOUPTFII 3T3-L1 CARΔ1 cells. In the RA at 0, 0.3,1,3, and 10 μM treatment
groups, protein levels of COUPTFII in differentiating ad-β-gal-transfected 3T3-L1
cells was obviously higher than that in the non-differentiating ad-β-gal-transfected
3T3-L1 CARΔ1 cells respectively. This result proved that COUPTFII can also be
induced during the process of differentiation. This result is very important
because it proved to us that ad-COUPTFII was successfully overexpressed by
ad-COUP-TFII in differentiated 3T3-L1 CARΔ1 cells which established the based
for our next research.
4.3.8 Differentiating ad-COUPTFII-transfected 3T3-L1 CARΔ1 Adipocytes
Treated with RA Further Decreases GLUT4 Protein Level
Fig 18 A shows the GLUT4 protein levels in ad-β-gal-transfected or adCOUPTFII -transfected 3T3-L1 CARΔ1cells treated with non-differentiation
medium or differentiation medium containing increasing concentrations of RA.
The cells and treatment were the same as Fig 17. Fig 18 B described the
quantification of GLUT4 protein in those cells.
The results of GLUT4 protein levels in β-gal-transfected 3T3-L1 cells were
the same as described in Fig. 16 A. Similar to the results in the groups of 3T3-L1
CARΔ1 cells with β-gal overexpression, GLUT4 protein levels in the nondifferentiating cells without RA was significantly lower than that in the
differentiating cells with COUPTFII overexpression. In the Ad-COUP-TFIItransfected 3T3-L1 CARΔ1 cells, the GLUT4 protein level in differentiating cells
treated with RA at 0, 0.3, 1, 3 or 10 μM were significantly lower than non71

A

B

Figure 18 GLUT4 protein levels in 3T3-L1 CARΔ1 adipocytes transfected with Ad-β-gal or
ad- COUPTFII. The cells were cultured in triplicates for five days in 3T3-L1 differentiation medium
(DM) containing 0, 0.3,1,3, or 10 μM RA. Ad-β-gal or ad- COUPTFII was added at Day 0 of
differentiation. DM was changed to maintenance medium after two days. Whole cell lysate was
collected on Day 7 as described in Materials & Methods. Blots were visually detected using ECL
Western Blotting Substrate. The ratio of the density of GLUT4 to that of β-Actin was calculated to
do data analysis with control group set as 1. A: A representative blot of protein levels of GLUT4
and β-actin in 3T3-L1 CARΔ1 adipocyte cell. B: Quantification analysis of GLUT4. All p-values İ
0.05, a>b>c>d>e>f>g>h, One-way ANOVA were used to analyse data (means ± S.E.M (n=3))
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differentiating cells treated without RA. GLUT4 protein level in differentiating cells
treated with RA at 0.3 or 1 μM were significantly higher than that in differentiating
cells treated with RA at 3 or 10 μM. GLUT4 protein level in differentiating cells
treated with 3 μM RA was significantly higher than differentiating cells treated
with RA at 10 μM. We conclude that RA may inhibit the GLUT4 protein level in a
dose dependent manner in Ad-COUP-TFII-transfected 3T3-L1 CARΔ1 cells.
Interestingly, we found protein levels of GLUT4 in 3T3-L1 CARΔ1 cells
with COUPTFII overexpression were significantly lower than the 3T3-L1 cells
with β-gal transfection in RA at 3 or 10 μM, respectively. We demonstrated that
COUPTFII was overexpressed successfully in differentiated 3T3-L1 CARΔ1 cells.
We conclude that the COUPTFII overexpression may facilitate the inhibitory
effects of RA on the expression of GLUT4.

4.4 Discussion
4.4.1 The inhibitory effect of RA on lipid accumulation in differentiating
3T3-L1 CARΔ1 cells may be mediated by RXRα
The effects of RA depend on its concentration and duration of action. It
has been shown that RA may block adipogenesis when introduced at early
stages of differentiation (24h).82 Moreover, it was shown that the inhibition of RA
on adipocyte differentiation via RA is mediated by RARs. 82 In the study, RA was
found to inhibit adipogenesis which was presented in Figure 13. Interestingly, we
found the adipogenesis was further inhibited in ad-RXRα-infected 3T3-L1 cells.
Overexpression of RXRα may help to mediate the inhibitory effect of RA on lipid
accumulation in differentiating 3T3-L1 CARΔ1 cells. This finding was different
from the results of Mitchell Lazar’s study that the inhibition influence of RA on
adipocyte differentiation were likely to be mediated by RARs rather than RXRs. 82
We hypothesize that the expression of RXRα in 3T3-L1 CARΔ1 cell may be too
low to present significant inhibit effects on adipocyte differentiation or RXRα
expression may be suppressed by the differentiation process.85
Here, we showed that overexpression of RXRα was achieved by ad-RXRα
in differentiating 3T3-L1 CARΔ1 adipocytes as described in Figure 15. 3T3-L1
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CAR Δ1 cells can be transduced effectively by recombinant adenovirus than
general 3T3-L1 cells. The overexpression of RXRα supports the finding that
RXRα may help to mediate the inhibitory effect of RA on lipid accumulation in
differentiating 3T3-L1 CARΔ1 cells.
Another difference between my study and Mitchell Lazar’s research is the
difference of RA concentrations used. We found that the overexpression of RXRα
may help to mediate the inhibitory effect of RA on lipid accumulation in
differentiating 3T3-L1 CARΔ1 cells when the concentration of RA was at 0.3 μM.
Whereas, Mitchell Lazar only examined the influence of 10 μM RA on lipid
accumulation in differentiating 3T3-L1 CARΔ1 cells.85
4.4.2 Overexpression of COUPTFII enhances the inhibitory effect of RA on
lipid accumulation in differentiating 3T3-L1 CARΔ1 cells
COUP-TFII expression is important in adipocyte differentiation. It has been
proved by Evan Rosen that overexpression of COUP-TFII in 3T3-L1
preadipocytes inhibits adipogenesis.86 As described in Figure 17 in my study,
COUPTFII was overexpressed successfully by recombinant adenovirus in 3T3L1 CARΔ1 adipocytes. We further proved that overexpression of COUPTFII may
inhibit the lipid accumulation in differentiating 3T3-L1 CARΔ1 cells. Previous
results of our lab have shown that overexpression of COUPTFII inhibited the RAinduced glucokinase gene expression in primary hepatocytes.81 However, in my
study, overexpression of COUPTFII did not attenuate the inhibition influence of
RA on lipid accumulation in differentiating 3T3-L1 CARΔ1 cells as described in
Figure 13 D.
4.4.3 RA-suppressed expression of GLUT4 is mediated by the expression
of RXRα proteins in 3T3-L1 cells
To understand the molecular pathogenesis of obesity and specifically the
role of RXRα in differentiation process of 3T3-L1 CARΔ1 cells, ad-RXRα was
used to transfect 3T3-L1 CARΔ1 cells and analyzed the expression levels of
GLUT4 protein. When RXRα was overexpressed in 3T3-L1 CARΔ1 cells, it
attenuated the inhibitory effects of RA on GLUT4 expression. GLUT4 protein
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level remains constant in the presence of RA. This result is totally new. It shows
that the RA-suppressed expression of GLUT4 probably is mediated by the
expression of RXRα proteins in 3T3-L1 cells. Although it is acknowledged that
total GLUT4 protein expression does not reflect the member-bound GLUT 4
which is considered the functional form to transport glucose into adipocytes, the
underlying mechanism about the change of total GLUT4 protein expression still
deserves to be futher investigated.
4.4.4 RA-suppressed expression of GLUT4 is enhanced by the expression
of COUPTFII proteins in 3T3-L1 cells
To understand the role of COUPTFII in differentiation process of 3T3-L1
CARΔ1 cells, ad-COUPTFII was used to overexpression it in 3T3-L1 CARΔ1
cells. Our results showed a reduction of GLUT4 expression, which is similar to
what has been observed by Evan Rosen. Their group also reported that the
GLUT4 protein level in differentiating adipocyte significantly decreased when
COUPTFII was overexpressed.86 Interestingly, different from RXRα,
overexpression of COUPTFII seems to facilitate the inhibitory effects of RA on
the expression of GLUT4. The inhibitory effects of RA on the expression of
GLUT4 was enhanced as a result. These results seem to indicate that the
relative amounts of RXRα and COUP-TFII in 3T3-L1 CARΔ1 cells probably play
an important role in mediating the RA effects on GLUT4 expression. Whether this
is the case remains to be investigated.

4.5 Conclusion:
Here, we found that the overexpression of RXRα or COUP-TFII inhibited
lipid accumulation in 3T3-L1 CARΔ1 cells, RA-mediated inhibition of lipid
accumulation in differentiating 3T3-L1 CARΔ1 cells may be facilitated by
overexpression of RXRα, but not COUP-TFII. Interestingly, the RA-inhibited
GLUT4 expression is attenuated by overexpression of RXRα and potentiated by
overexpression of COUP-TFII. The findings shown here will help us to
understand the roles of nutrients and hormones in the control of functions of
adipocytes, and in turn, the pathogenesis of obesity.
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CHAPTER FIVE
CONCLUSIONS AND FUTURE DIRECTIONS
5.1 Conclusions
Skeletal muscle and adipose tissues play key roles in lipid and glucose
metabolism. These are achieved through their responses to nutritional and
hormonal stimulation. We demonstrated in this thesis that VA and insulin may
work together to regulate macronutrient metabolism in cells. As a metabolite of
VA and the main mediator of its actions, RA regulates transcription of genes. We
aimed to find the effects of RA on the GLUT4 expression levels in L6 muscle
cells and 3T3-L1 CARΔ1 adipocytes with or without insulin. Understanding the
mechanism by which how RA influences macronutrient metabolism helps us to
better control obesity and type 2 diabetes. This thesis contains two parts. Studies
in the first part were conducted in L6 myocytes, which is a good model to study
glucose metabolism and differentiation process in skeletal muscle. Studies in the
second part were conducted in 3T3-L1 CARΔ1 cells, which is a good model to
study adipocyte metabolism and preadipocyte differentiation. Compared with the
parental 3T3-L1 cells, 3T3-L1 CAR Δ1 cells allow the transduction of genetic
materials through the use of recombinant adenoviruses, which is an important
feature for us to study the functions of transcription factors affecting RA signaling.
We showed here that both RA and insulin inhibit the expression levels of
GLUT4 in L6 cells after 4 and 6 days of treatment. Interestingly, the synergy
effects between RA and insulin can be seen at Day 4 with RA at 1 μM. In the
differentiating 3T3-L1 CARΔ1 cells, RA treatment leads to the decrease of lipid
accumulation in 3T3-L1 CARΔ1 cells during the cell differentiation in this study.
Additionally, overexpression of RXRα enhanced the inhibitory effects of RA on
lipid accumulation in RA 0.3 μM group. RA treatment reduced the expression
levels of GLUT4 and RXRα in differentiating 3T3-L1 CARΔ1 cells.
Overexpression of RXRα attenuated the RA-inhibited GLUT4 expression. Other
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the other hand, the inhibitory effects of RA on GLUT4 expression can be
enhanced with COUPTFII overexpression.
We conclude that GLUT4 expression in both L6 and 3T3-L1 CARΔ1 cells
can be reduced in the presence of RA. In addition, RA synergizes with insulin to
reduce GLUT4 expression in L6 cells. RA-inhibition of GLUT4 expression in 3T3L1 CARΔ1 cells may be mediated by the reduction of RXRα expression by RA.

5.2 Future Directions
We hope that our finding about the synergistic effects of RA and insulin on
GLUT4 expression in L6 cells will bring attention of clinicians regarding the
potential effects of VA supplement in patients with obesity and diabetes. Insulin
resistance is commonly found in patients with obesity and diabetes . There is a
possibility that the insulin in plasma level is significantly high. If the patients with
diabetes or obesity intake VA supplements, their insulin in plasma and VA may
have a synergistic effect to inhibit the GLUT4 protein level in skeletal muscle
which is not good for the entry of glucose into the tissue.
Previous results from the lab showed that glucose usage of differentiated
skeletal muscle cells treated with RA and insulin for 4 days increase
significantly.81 The decrease protein level of GLUT4 cannot explain the increase
of glucose usage of L6 cells. The reason may be that GLUT1 and GLUT3 were
also expressed in skeletal muscle. It was found GLUT1 decreased in L6 cells
treated the same way. Whereas, he has observed the induction of GLUT3 and
GLUT6 expression levels after RA and insulin treatments. I have not measured
the expression levels of these GLUTs. We hypothesize glucose probably gets
into the cells through other GLUTs since the L6 cells treated with RA and insulin
have the increase of glucose usage. In the future, we plan to study the GLUT1,
GLUT3 and GLUT6 expression in L6 cells. However, GLUT4 is not the only type
of GLUTs expressed in skeletal muscle.
The GLUT4 expression is inhibited by RA in 3T3-L1 CARΔ1 cells. We
have not examine whether there is a synergy of RA and insulin in the regulation
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of GLU4 expression in adipocytes. Future experiment to determine what the role
of insulin is in the RA-inhabited GLUT4 expression are needed.
In addition, we also demonstrated that 3T3-L1 CARΔ1 cells is an effective
cell line to test the roles of RXRα and COUP-TFII in GLUT4 expression. These
cells will also be used to investigate the functions of other transcription factors to
mediate insulin and RA responses in adipocytes.

5.3 Summary
The data presented here in my study help us to understand the influence
of RA in expression levels of proteins for glucose metabolism in both skeletal
muscle and adipocytes. The synergistic effect of RA and insulin on GLUT4
expression suggests that the use of VA supplements in people with diabetes or
obesity should be cautious. The results of GLUT4 expression and RXRα
overexpression in 3T3-L1 CARΔ1 cells demonstrate the potential to use this cell
line for the study of regulation of gene expression in adipocytes. In summary, the
work presented here lays the foundation for understanding the glucose
metabolism and pathology of chronic disease like diabetes or obesity in the body.
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